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Three Essays On Diabetes And Mortality In The United States 
Abstract 
Diabetes is on the rise. The world faces an emerging deadly threat on people’s health and nations’ public-
health systems with a large economic burden. According to the World Health Organization (WHO), the 
number of people living with diabetes has risen from 108 million in 1980 to 422 million in 2014 (WHO, 
2016). In the United States, more than 80 million people are living with diabetes or prediabetes and this 
number is projected to double by 2050 (CDC, 2017). 
Diabetes is a serious and life-threatening condition that occurs when the body cannot regulate blood 
sugar. When diabetes is not appropriately controlled, it causes dire consequences for health and well-
being of individuals. Furthermore, compelling empirical evidence has shown a strong association 
between diabetes and premature death (Gu, Cowie and Harris, 1998). In 2016, the number of deaths in the 
world due to diabetes was 1.6 million and this number is expected to increase (WHO, 2016). Thus, 
reducing excess deaths from diabetes has been one of the main goals of global efforts, such as 2030 
Agenda for Sustainable Development developed by the WHO (UN General Assembly, 2015). Accordingly, 
public health policy makers and health providers have called for better diabetes prevention interventions 
and disease management programs designed to reduce the risk of mortality due to diabetes. 
This dissertation aims to contribute to these efforts by filling critical gaps in the previous literature on 
diabetes and mortality. The gaps this dissertation focuses on are threefold. First, the fraction of total 
deaths attributable to diabetes is seriously underestimated when an underlying cause of death on death 
certificates is used to assess the contribution of diabetes to overall mortality, which is a commonly used 
method to assess the contribution of diabetes to a national mortality profile. Second, despite a body of 
literature on the association between diabetes and mortality, few prospective studies have examined this 
association by using information on self-reported diagnosed diabetes and biomarkers of diabetes 
measured at the start of the mortality follow-up (or baseline) simultaneously. Third, prior findings on 
nativity disparities in diabetes in the United States have been inconsistent and most studies have relied 
solely on self-reported diabetes, which may be biased due to immigrants’ limited access to healthcare. 
Each of these three gaps is addressed in the following chapters. In Chapter 1, I examine the contribution 
of diabetes to US life expectancy using a Population Attributable Fraction (PAF) approach. I found that life 
expectancy at age 30 increases by 0.89 years when diabetes is eliminated based on the PAF, and this 
estimate is much higher than a gain of 0.34 years based on underlying cause of death data. In Chapter 2, I 
estimate the risk of death associated with diabetes using both self-reported diagnosed diabetes and a 
level of HbA1c measured at baseline. Results show that self-reported diagnosed diabetes had a stronger 
association with mortality than HbA1c at baseline, and individuals with self-reported diagnosed diabetes 
were at a higher risk of death compared to those whose diabetes had not been previously diagnosed, 
regardless of their diabetes status identified by baseline HbA1c level. In Chapter 3, I examine nativity 
differentials in diabetes using self-reported diagnosed diabetes, HbA1c and undiagnosed diabetes. I find 
that the foreign-born have a higher prevalence of diabetes than the US-born individuals, but that this 
excess was explained by controls for sociodemographic characteristics and Body Mass Index (BMI). In 
addition, I observe that among the foreign-born, those who had arrived in the United States in the last 15 
years were less likely to have self-reported diabetes than those who had arrived earlier, suggesting that 
the immigrant health advantage deteriorates with time in the United States. When diabetes was 
diagnosed based on baseline HbA1c level, however, there was no such advantage for the short-term 
immigrants over the long-term immigrants. 
These findings suggest avenues for future research. First, it is important to consider the various ways in 
which information on diabetes is collected in surveys and on death certificates in assessing its impact on 
mortality. The results from Chapter 1 show that a focus on diabetes as an underlying cause of death 
seriously underestimates its impact on life expectancy. Furthermore, Chapter 2 demonstrates that self-
reported diagnosis of diabetes provides important information about the risk of death due to diabetes 
beyond biomarkers measured at the start of the mortality follow-up. Thus, future studies need to consider 
multiple ways in which diabetes is measured. Second, in Chapters 2 and 3, the issue of measurement is a 
key focus and results from these chapters suggest that diverse measurements of diabetes should be 
considered at the same time, not only because they reflect different aspects of diabetes, but also using 
them together provides more comprehensive information on how diabetes is associated with mortality. 
Third and most importantly, future research should seek to understand the mechanisms through which 
diabetes contributes to mortality. Because all three chapters of this dissertation are based on cross-
sectional data, the current dissertation cannot directly examine the connections that link the onset of 
diabetes to subsequent mortality. Patients who are diagnosed with diabetes are likely to experience 
several changes in their life, such as modifications in health behaviors, using healthcare services and 
taking medicine to control diabetes, and change the perception of their own health, which are likely to 
affect the risk of death. Therefore, future research that accounts for these modifications will shed light on 
the mechanisms associated with the onset of diabetes and subsequent mortality. 
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INTRODUCTION 
 
Diabetes is on the rise. The world faces an emerging deadly threat on people’s health 
and nations’ public-health systems with a large economic burden. According to the World 
Health Organization (WHO), the number of people living with diabetes has risen from 108 
million in 1980 to 422 million in 2014 (WHO, 2016). In the United States, more than 80 
million people are living with diabetes or prediabetes and this number is projected to double by 
2050 (CDC, 2017).  
Diabetes is a serious and life-threatening condition that occurs when the body cannot 
regulate blood sugar. When diabetes is not appropriately controlled, it causes dire 
consequences for health and well-being of individuals. Furthermore, compelling empirical 
evidence has shown a strong association between diabetes and premature death (Gu, Cowie 
and Harris, 1998). In 2016, the number of deaths in the world due to diabetes was 1.6 million 
and this number is expected to increase (WHO, 2016). Thus, reducing excess deaths from 
diabetes has been one of the main goals of global efforts, such as 2030 Agenda for Sustainable 
Development developed by the WHO (UN General Assembly, 2015). Accordingly, public 
health policy makers and health providers have called for better diabetes prevention 
interventions and disease management programs designed to reduce the risk of mortality due to 
diabetes.  
This dissertation aims to contribute to these efforts by filling critical gaps in the 
previous literature on diabetes and mortality. The gaps this dissertation focuses on are 
threefold. First, the fraction of total deaths attributable to diabetes is seriously underestimated 
when an underlying cause of death on death certificates is used to assess the contribution of 
diabetes to overall mortality, which is a commonly used method to assess the contribution of 
 
x 
 
diabetes to a national mortality profile. Second, despite a body of literature on the association 
between diabetes and mortality, few prospective studies have examined this association by 
using information on self-reported diagnosed diabetes and biomarkers of diabetes measured at 
the start of the mortality follow-up (or baseline) simultaneously. Third, prior findings on 
nativity disparities in diabetes in the United States have been inconsistent and most studies 
have relied solely on self-reported diabetes, which may be biased due to immigrants’ limited 
access to healthcare.   
Each of these three gaps is addressed in the following chapters. In Chapter 1, I 
examine the contribution of diabetes to US life expectancy using a Population Attributable 
Fraction (PAF) approach. I found that life expectancy at age 30 increases by 0.89 years when 
diabetes is eliminated based on the PAF, and this estimate is much higher than a gain of 0.34 
years based on underlying cause of death data. In Chapter 2, I estimate the risk of death 
associated with diabetes using both self-reported diagnosed diabetes and a level of HbA1c 
measured at baseline. Results show that self-reported diagnosed diabetes had a stronger 
association with mortality than HbA1c at baseline, and individuals with self-reported 
diagnosed diabetes were at a higher risk of death compared to those whose diabetes had not 
been previously diagnosed, regardless of their diabetes status identified by baseline HbA1c 
level. In Chapter 3, I examine nativity differentials in diabetes using self-reported diagnosed 
diabetes, HbA1c and undiagnosed diabetes. I find that the foreign-born have a higher 
prevalence of diabetes than the US-born individuals, but that this excess was explained by 
controls for sociodemographic characteristics and Body Mass Index (BMI). In addition, I 
observe that among the foreign-born, those who had arrived in the United States in the last 15 
years were less likely to have self-reported diabetes than those who had arrived earlier, 
suggesting that the immigrant health advantage deteriorates with time in the United States. 
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When diabetes was diagnosed based on baseline HbA1c level, however, there was no such 
advantage for the short-term immigrants over the long-term immigrants.  
These findings suggest avenues for future research. First, it is important to consider the 
various ways in which information on diabetes is collected in surveys and on death certificates 
in assessing its impact on mortality. The results from Chapter 1 show that a focus on diabetes 
as an underlying cause of death seriously underestimates its impact on life expectancy. 
Furthermore, Chapter 2 demonstrates that self-reported diagnosis of diabetes provides 
important information about the risk of death due to diabetes beyond biomarkers measured at 
the start of the mortality follow-up. Thus, future studies need to consider multiple ways in 
which diabetes is measured. Second, in Chapters 2 and 3, the issue of measurement is a key 
focus and results from these chapters suggest that diverse measurements of diabetes should be 
considered at the same time, not only because they reflect different aspects of diabetes, but also 
using them together provides more comprehensive information on how diabetes is associated 
with mortality. Third and most importantly, future research should seek to understand the 
mechanisms through which diabetes contributes to mortality. Because all three chapters of this 
dissertation are based on cross-sectional data, the current dissertation cannot directly examine 
the connections that link the onset of diabetes to subsequent mortality. Patients who are 
diagnosed with diabetes are likely to experience several changes in their life, such as 
modifications in health behaviors, using healthcare services and taking medicine to control 
diabetes, and change the perception of their own health, which are likely to affect the risk of 
death. Therefore, future research that accounts for these modifications will shed light on the 
mechanisms associated with the onset of diabetes and subsequent mortality.  
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ABSTRACT 
 
THREE ESSAYS ON DIABETES AND MORTALITY IN THE UNITED STATES 
Daesung Choi 
Irma Elo 
The dissertation aims to contribute to the ongoing debate on diabetes and 
mortality by filling critical gaps unanswered in previous literature. Chapter 1 estimates 
the contribution of diabetes on U.S. life expectancy using a Population Attributable 
Fraction approach. Data are from National Health and Interview Survey 1997-2009 
and Linked Mortality Files through 2011, and the official 2010 U.S. life tables. I found 
that life expectation at age 30 increases by 0.89 years when diabetes is eliminated, and 
this estimate is much higher than a gain of 0.34 years based on underlying cause of 
death data. Chapter 2 investigates an association between diabetes and all-cause 
mortality by considering self-reported diagnosed diabetes and HbA1c simultaneously. 
Data are drawn from the National Health and Nutrition Examination Survey 
(NHANES) 1988-1994, continuous NHANES 1999-2009 and Linked Mortality Files 
through December 31, 2015. In primary analyses, the sample adults ages 30 to 84 are 
categorized by self-reported diabetes and HbA1c criteria of ≥ 6.5%. Then relative risk 
of death among these groups is estimated. When both measurements are jointly 
considered in survival analysis, self-reported diabetes shows a much stronger 
association with mortality than baseline HbA1c criteria. Results show that adults with 
diagnosed diabetes are at an increased risk of death than those without diagnosed 
diabetes, regardless of their baseline HbA1c status. Chapter 3 examines the existence 
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of an immigrant health advantage in diabetes among the foreign-born compared to 
their U.S.-born counterparts ages 30 to 80 using both self-reported diabetes and HbA1c 
levels. Data used in this chapter are NHANES 1988-1994 and continuous NHANES 
1999-2015. Logistic regression models are estimated to examine relative risk of self-
reported diabetes, HbA1c ≥6.5% and undiagnosed diabetes among the foreign-born 
relative to the U.S.-born. I found that A racial/ethnic composition and BMI play a role 
in nativity disparities in diabetes. In addition, the foreign-born advantage in self-
reported diabetes among those who have resided in the United States for less than 15 
years is in part due to their higher prevalence of undiagnosed diabetes compared to that 
of the US-born.  
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CHAPTER 1  
 
EFFECT OF DIABETES ON LIFE EXPECTANCY  
IN THE UNITED STATES BY RACE/ETHNICITY AND GENDER1 
 
Abstract 
Background: The estimation of mortality attributable to diabetes has been typically 
made based on information on death certificates which underestimates the true impact of 
diabetes on the national mortality profile. Using Population Attributable Fraction (PAF), 
this chapter estimates age-sex-race/ethnicity specific fraction of total deaths attributable 
to diabetes in the United States. In addition, this chapter assesses the impact of diabetes 
on life expectancy above age 30 by sex and race/ethnicity using PAFs.  
Data and Methods: Data are from the public use 1997-2009 National Health Interview 
Survey (NHIS) and Linked Mortality Files (LMF) and the official 2010 US life tables for 
the entire US population and by sex and race/ethnicity. Mortality status of adults aged 30 
and above were followed up from the survey through December 31, 2011. The outcome 
is all-cause mortality and diabetes is identified by self-reported diagnosed diabetes. PAF 
is a function of hazard of death associated with diabetes and prevalence of diabetes 
among decedents. Hazard ratios are estimated by fitting Cox Proportional hazard models. 
Estimated PAFs are applied to the US life table to obtain mortality rates and life 
expectancy in the absence of diabetes. I also estimate the impact of diabetes on life 
expectancy using the underlying cause of death data obtained from NHIS-LMF. 
Results: Diabetes was responsible for a reduction of 0.83 and 0.89 years of life 
expectancy for men and women at age 30, respectively. Non-Hispanic blacks and 
Hispanics have higher prevalence of diabetes among deaths, but lower hazard of death 
associated with diabetes compared with non-Hispanic whites. This results in comparable 
PAF values and gains in life expectancy across race/ethnicity. Gains in life expectancy 
based on an underlying cause of death are 0.33 for both men and women at age 30. 
Conclusion: The number of deaths attributable to diabetes based on an underlying 
cause of death is greatly underestimated. The more realistic estimation of mortality 
rates attributable to diabetes should be employed to better identify the burden of 
diabetes. 
 
 1 A version of this chapter has been previously published as appeared in Samuel H. Preston, Daesung 
Choi, Irma T. Elo & Andrew Stokes (2018) Effect of diabetes on life expectancy in the United States by 
race and ethnicity, Biodemography and Social Biology, 64:2, 139-151, DOI: 
10.1080/19485565.2018.1542291  
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1.1 Introduction 
For the past decades, the prevalence of diabetes has increased dramatically in 
the United States. In 1980, the age-adjusted prevalence of diagnosed diabetes was 
3.7%, but increased to 8.3% in 2012 (Geiss et al., 2014). If current trends continue, the 
number of people with diabetes is estimated to be 60.6 million in 2060, accounting for 
17.9% of the total US population (Lin et al., 2018). As diabetes is one of the most 
costly chronic diseases, the increasing number of adults with diabetes will impose a 
substantial burden on healthcare resources in the future (American Diabetes 
Association 2018).   
Diabetes is associated with excess deaths and multiple complications, including 
cardiovascular disease, stroke, cancer and hypertension (Gregg, Li, et al., 2014; 
Saydah, Tao, Imperatore, & Gregg, 2009). The effect of diabetes on national mortality 
profiles has been typically estimated based on national surveillance data that collect 
information from death certificates (McEwen et al., 2006). Many researchers, however, 
have pointed out that these estimates calculated based on an undying cause of death 
may seriously underestimate the actual impact of the disease on the mortality profile of 
the US population (Alva, Hoerger, Zhang, & Cheng, 2018; Roglic et al., 2005; Stokes 
& Preston, 2017). The reason is that people with diabetes often die from diabetes 
complications, especially cardiovascular events, rather than diabetes itself and these 
complications tend to be mentioned as an underlying cause of death and diabetes may 
not be listed anywhere on death certificates (Murray et al., 2008; Saydah et al., 2004). 
One way to avoid this limitation is to use a Population Attributable Fraction (PAF) 
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approach, with which the fraction of total deaths attributable to diabetes in a population 
can be estimated based on national survey data in which persons who have diabetes are 
identifiable before death.  
To date, many studies have employed the PAF approach to estimate the more 
realistic contribution of diabetes to mortality (Alva et al., 2018; Roglic et al., 2005; 
Stokes & Preston, 2017). One limitation of these studies is that the literature did not 
estimate PAFs separately by age, sex and race/ethnicity. Given considerable 
heterogeneity in terms of the prevalence of diabetes and mortality by these 
demographic characteristics, an estimate for the entire US population does not capture 
how diabetes affects mortality by such sociodemographic characteristics.  
Therefore, this chapter aims to estimate age-specific PAFs for males and 
females and racial/ethnic groups separately. Then the estimated PAFs will be applied 
to the official US life tables to obtain gain in life expectancy when eliminating deaths 
attributable to diabetes by sex and race/ethnicity. Furthermore, gains in life expectancy 
and probability of dying in the absence of diabetes based on PAFs will be compared 
with values based on an underlying cause of death. 
 
1.2 Literature Review 
1.2.1 Trends in Diabetes Prevalence and Mortality 
The number of people with diabetes in the world has increased at an alarming 
rate. An estimated number of adults living with diabetes was 108 million in 1980 and 
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this number has more than tripled by 2014 (Zhou et al., 2016). The United States is not 
the exception in this global diabetes epidemic. The nationwide age-adjusted prevalence 
of people with self-reported diagnosed diabetes among adults aged 20-79 increased 
from 3.7% in 1980 to 8.3% in 2012, and the rapid increase was particularly prominent 
between 1990-2008 (Geiss et al. 2014). When measured by either a diagnosis of 
diabetes or HbA1c ≥ 6.5%, the prevalence among adults increased from 6.2% to 9.9% 
between 1988-1994 and 2005-2010 (Selvin, et al., 2014). Despite these trends since the 
1990s, a slowing, or even decreasing rate of growth of the diabetes epidemic has been 
observed in recent national statistics; the estimated annual percentage change in rates 
of the prevalence of diabetes reduced from 4.5% in 1990-2008 to 0.6% in 2009-2012 
(Geiss et al., 2014). Many factors may contribute to this recent leveling off, such as 
changes in diagnostic criteria for diabetes (Selvin & Ali, 2017) and improvements in 
risk factor management (Menke et al., 2014). 
Recent studies also show notable reductions in mortality rates among people with 
diabetes. Age-standardized death rates in people with diabetes declined by 20% in every 
10 years during 1985-2015 (from 23.1 to 15.2 per 1000 person-years) and such decrease 
was largely attributable to the reduction in the number of deaths from vascular disease in 
people with diabetes (Gregg et al., 2018). Another national study shows that 
cardiovascular disease death rates among people with diabetes have dropped from 11.2 to 
5.2 per 1000 person-years between 1988 and 2015 (Cheng et al., 2018). It has been also 
found that the number of years of life lost due to diabetes has been reduced by 1.8 years 
for men and 0.3 years for women at age 40 with self-reported diagnosed diabetes between 
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1985-1989 and 2000-2011 (Gregg, Zhuo, et al., 2014). These trends of reducing mortality 
risk among people with diabetes result in a decrease in relative mortality risk between 
people with and without diabetes. However, one study by Stokes and Mehta (2013) 
reported that all-cause mortality rates among US adults aged 35-74 with prediabetes 
(HbA1c levels between 5.7% and 6.4%) has increased from 11.19 to 14.02 per 1,000 
person-years between 1988-2001 and 1999-2006 (Stokes & Mehta, 2013), suggesting that 
changes in mortality risks could vary by types of diabetes. 
 1.2.2 Mortality and Race/Ethnicity 
Despite substantial improvements in longevity for most Americans since the 
1990s, significant racial/ethnic disparities in mortality have largely remained (Borrell & 
Lancet, 2012). According to the National Center for Health Statistics (NCHS), life 
expectancy at birth of the US population increased from 76.8 years to 78.8 years (from 
74.1 years to 76.2 years for males and from 79.3 years to 81.0 years for females), but 
racial gaps in life expectancy remained substantial; in 2016, life expectancy at birth was 
78.5, 74.8 and 81.8 years for non-Hispanic Whites (Whites hereafter), non-Hispanic 
Blacks (Blacks hereafter) and Hispanics, respectively. Thus, identifying and eliminating 
the sources of mortality disparities by race/ethnicity has long been one of the primary 
goals of public health interventions (Hummer, Rogers, Nam, & LeClere, 1999; National 
Research Council. 2004).  
To date, a variety of factors, from biological and individual factors to contextual 
factors, have been proposed to explain racial disparities in mortality and longevity 
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(Williams & Sternthal, 2010). Among these factors, much attention has been paid to 
overweight/obesity and smoking as many racial minorities commonly show higher 
prevalence of these health indicators than Whites, and also these factors have been found 
to be strongly associated with excess death (Cossrow & Falkner, 2004; Elo, Mehta, & 
Preston, 2017; Ho & Elo, 2013). For instance, using data from the National Health and 
Nutrition Examination Survey (NHANES), Elo, Preston and Mehta (2017) found that 
different BMI distributions accounted for about 30% and 1% of Black-White difference 
in mortality among women and men, respectively (Elo, Preston and Mehta, 2017). 
Likewise, Ho and Elo (2013) reported that smoking accounted for approximately 23% of 
Black-White difference in life expectancy among men at age 50 in 2005 (Ho & Elo, 
2013). Despite a body of studies on smoking and BMI, relatively little is known about the 
contribution of diabetes to the racial gap in mortality. What has been commonly done is 
comparing the mortality risk of people with diabetes to that of people without diabetes by 
race/ethnicity. Although such comparison provides information about the distribution of 
diabetes-mortality patterns across race/ethnicity, this approach does not evaluate whether 
and to what degree mortality gaps by race/ethnicity would be reduced if diabetes were 
eliminated.   
1.2.3 Diabetes and Race/Ethnicity  
It is now well-documented that racial minorities have a higher prevalence of 
diabetes compared to Whites. In 2013-2015, the age-adjusted prevalence of diagnosed 
diabetes was estimated to be 12.7% among Black and 12.1% among Hispanic adults, 
while Whites showed a significantly lower prevalence of 7.4% (Centers for Disease 
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Control, 2017). The same pattern was observed with total diabetes, either having been 
diagnosed with diabetes or have HbA1c levels ≥ 6.5%: among adults aged 20 or older, 
the prevalence in 2015-2016 were 11.5%, 18.4% and 18.3% in Whites, Blacks and 
Hispanics, respectively (Feng, 2018). The higher risk of diabetes in Blacks and Hispanics 
than Whites is also evident by the lifetime risk of developing diabetes; the estimated 
lifetime risks of diabetes at birth for males was found to be 26.7% among Whites, 40.2% 
among Blacks and 45.4% among Hispanics (Narayan et al., 2003).  
Many risk factors are associated with the observed higher diabetes prevalence 
among racial minorities including higher prevalence of obesity, lower socioeconomic 
status, poorer access to preventive care and physical inactivity among Blacks and 
Hispanics. Among these factors, obesity/overweight has frequently been pointed out as a 
major cause because the distribution of obesity/overweight has been found to be largely 
paralleled with the distribution of diabetes across racial/ethnic groups, and the prevalence 
of diabetes in recent years has increased simultaneously with an increase in obesity 
among US adults (Hedderson et al., 2012). However, some studies have reported that 
BMI is only marginally associated with racial disparities in diabetes. Brancati et al. 
(1996), for instance, examined the role of SES and BMI and found that the Black-White 
difference in diabetes prevalence was not explained by these two factors, and that Blacks 
were over twice as more likely to have diabetes compared to Whites even after 
controlling for SES and BMI (Brancati et al., 1996). On the other hand, several studies 
have shown that racial disparities in diabetes vary by types of diabetes. When looking at 
gestational diabetes, the age-adjusted prevalence was found to be higher among White 
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women than African American women in the United States (Hedderson et al., 2012) In 
addition, the incidence of type 1 diabetes was also higher among White (15.1 per 100,000 
person-years) than Black (11.1) and Hispanic (12.1) youth aged 15-19 (Youth Study 
Group et al., 2007). Other studies emphasized the importance of the country of origin. 
Among Latinos, for instance, prevalence of diabetes was much higher for those from 
Mexico, Puerto Rico and Central America than those from Cuba and South America 
(Spanakis and Golden, 2013). Such variation is also found among Asian subpopulations 
in the United States: Asian Indians showed the highest age-adjusted prevalence (14.2%) 
and those from Korea (4.0%), Japan (4.9%) and China (6.2%) had relatively low 
prevalence in 2004-2006 (Barnes et al., 2008).  
Although Blacks and Hispanics show higher prevalence of diabetes compared to 
Whites, it is not clear that mortality risk associated with diabetes is also higher for Blacks 
and Hispanics than for Whites. Based on data from death certificates in 2016, the age-
adjusted death rates from diabetes were 18.6% among Whites, 37.8% among Blacks and 
25.7% among Hispanics, indicating the mortality rates for diabetic Blacks and Hispanics 
are 2.03 and 1.38 times higher than those of diabetic Whites (Xu et al, 2018). However, a 
randomized controlled study of 1,750 participants with type 2 diabetes and coronary 
artery disease demonstrated that there were no significant mortality differentials between 
Whites, Blacks and Hispanics during 5-years follow-up (Beohar et al., 2013). Also, 
Conway et al. (2014) who investigated cause-specific mortality among low-income 
Blacks and Whites aged 40-79 with type 2 diabetes found that Blacks had a lower risk of 
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death from ischemic heart disease or respiratory disorders than Whites (Conway et al., 
2015).  
1.2.4 Population Attributable Fraction of Diabetes 
US national surveillance reports commonly use data from death certificates 
collected from all localities across the United States to determine the frequency of total 
deaths by causes of death. According to the National Vital Statistics Reports published 
in 2018, there were 80,056 death certificates that mentioned diabetes as the underlying 
cause of death, which accounted for approximately 2.9% of the total death 
certifications in 2016 (Xu et al., 2018). The World Health Report 2003 also estimates 
deaths by specific causes in WHO regions using the underlying cause. This report 
shows that there were 987,000 deaths due to diabetes in 2002 and this number 
accounted for 1.7% of the total deaths in the same year (WHO, 2003). Furthermore, the 
National Center for Health Statistics (NCHS) produces years of life lost due to diabetes 
by eliminating of deaths based on the underlying cause. According to the report, the 
gain in life expectancy at age 30 is 0.34 years in 1999-2001 (Arias, Heron and Teleda-
Vera, 2013). These estimates obtained based on death certificate data have been 
frequently cited by researchers and policy makers to address the burden of diabetes on 
the public health of the US population (McEwen et al., 2006). 
However, scholars have consistently argued that the number of deaths attributable 
to diabetes estimated based on death certificates could be seriously underreported. This is 
because diabetes is often not considered as an underlying or contributing cause of death 
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even though a decedent has diabetes (Murray et al., 2008; Saydah et al., 2004). Thus, 
estimating deaths attributable to diabetes based on diabetes reported in a death certificate 
fails to account for all decedents with diabetes, which leads to an underestimation of the 
impact of the disease on a nation’s mortality.  
Such limitation has been confirmed by numerous studies. These studies typically 
calculate the proportion of individuals who were listed with diabetes as an underlying 
cause of death on the death certificate among all individuals with diagnosed diabetes. For 
instance, using NHANES 1971-1975, Gu (1988) found that only 36.0% of diabetic men 
and 47.2% of diabetic women who died had diabetes listed anywhere on the death 
certificate and the probability that diabetes is listed as the underlying cause is low, 
ranging from 10% to 15% (Gu et al., 1998). Using 1986 National Mortality Followback 
Survey, Bild and Stevenson (1991) also found very low sensitivity of death certificate 
data; among 2,766 decedents with known diabetes, about 9.6% of deaths had diabetes as 
the underlying cause of death on a death certificate (Bild & Stevenson, 1992). One study 
by Saydah et al. (2004) that focuses on the assessment of diabetes measurement 
summarized the sensitivity of underlying cause data reported in previous studies, and the 
observed values range from 7.1% to 29.8%, suggesting that the frequency of recording of 
diabetes on death certificates is considerably underreported to reflect the true impact of 
diabetes (Murray et al., 2008; Saydah et al., 2004). The major problem of this 
underestimation is the low reliability and validity of cause of death information on death 
certificates and the large variation in interpreting and diagnosing primary causes of death 
(McEwen et al., 2006). Another reason is that, in many cases, physicians who are 
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required to complete a death certificate are not always able to identify whether a decedent 
had diabetes at the time of death and thus whether diabetes is mentioned on a death 
certificate is highly variable even though the decedent had diabetes.  
One way of avoiding the limitation is to use the PAF. Using this approach, it is 
possible to quantify a contribution of a risk factor to total deaths in a population based on 
survey data in which people’s diabetes status can be identified before death. Although 
defined in various ways, in general, PAF is defined as the proportional reduction in 
deaths, or a disease risk, in a specific time period if a risk factor were eliminated or 
reduced to a hypothetical level over a specific time period (Rockhill, Newman, & 
Weinberg, 1998; Smith, Schellenberg, & Hayes, 1994).  
The PAF has been employed in many studies of diabetes. For example, Roglic 
et al. (2005) estimated the number of deaths attributable to diabetes in African, 
American, Eastern Mediterranean, European Southeast Asia and Western Pacific 
regions in 2000 (Roglic et al., 2005). Roglic et al. reported that the fraction of global 
mortality that is attributable to diabetes is 5.2% (2.9 million deaths) and the fraction is 
higher in North America (8.5%) and Middle East (9%) than the poorest African 
countries (2.4%). Alva et al. (2018) applied the PAF approach to estimate state-level 
diabetes-attributable mortality from all causes and from causes specific to 
cardiovascular diseases using the Behavioral Risk Factor Surveillance System and the 
NHIS 2005-2009 and LMF through 2011. Results from their analyses showed that the 
number of excess deaths attributable to diabetes in 2013 were 156,000 and 137,000 
deaths in men and women, respectively. These values were combined to account for 
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11% of the total deaths in the year 2013, which is almost four times the estimates when 
diabetes is listed as the underlying cause (Alva et al., 2018). Stokes and Preston (2017) 
also estimated the fraction of deaths attributable to diabetes in the US population ages 
30-84 using a nationally representative sample. In their study, the attributable fraction 
of total deaths due to diabetes was about 11.8%, which is much greater than a value of 
3.4% based on death certificates as the underlying cause of death (Stokes & Preston, 
2017). The PAF has been also used for smoking and overweight/obese (Mehta & 
Chang, 2009; Ho & Elo, 2013; Preston, Glei, & Wilmoth, 2010). For instance, Ho and 
Elo (2013) found that smoking is responsible for 33.1% of deaths of black men and 
29.7% of deaths of white men aged 50 to 84 in the 1997-2003 survey cohorts. A 
similar method was applied to BMI analysis; Mehta and Chang (2009) found that class 
Ⅱ/Ⅲ (BMI ≥ 35.0) is responsible for 3-4% of all deaths among people ages 50-61 in 
1992-2004 in the US.  
One limitation of the previous literature of diabetes is that previous studies do not 
estimate the contribution of diabetes to the national mortality by age, sex and 
race/ethnicity. Due to this limitation, it is still unclear whether the impact of diabetes to 
mortality varies by age groups, sex and race/ethnicity. In addition, little is known about 
whether and to what extent eliminating diabetes reduces mortality disparities between 
sexes and racial/ethnic groups. Prior studies have shown that, however, age, sex and 
race/ethnicity are important risk factors for diabetes, and there is a large variation in 
diabetes rates by these three factors (Davidson & Schriger, 2010; Fishman, Stokes, & 
Preston, 2014).  
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1.3 Aims of Chapter 1 
The aims of this chapter are threefold. First, I will estimate age-specific PAFs due 
to diabetes separately by sex and race/ethnicity. Second, using estimated PAF values, I 
will estimate the contribution of diabetes to life expectancy by sex and race/ethnicity. 
Third, I will compare these estimates based on PAFs to values calculated based on the 
underlying cause of death data.  
1.4 Data and Methods 
1.4.1 Data and Sample 
Two data sources are used in this chapter: the public use 1997-2009 National 
Health Interview Survey and Linked Mortality Files (NHIS-LMF) and the official 
2010 US life tables for the entire US population and by sex and race/ethnicity. NHIS is 
a nationally representative, cross-sectional survey of the non-institutionalized 
population in the United States. The NCHS has linked respondents in NHIS to death 
certificate records in the National Death Index (NDI). Adults who are eligible for the 
linkage were followed up from the survey date through December 31, 2011 (National 
Center for Health Statistics 2016). The second data are drawn from 2010 US life 
tables. In the life tables, age and sex specific mortality rates are presented for Whites, 
Blacks and Hispanics. Using these rates in combination with estimates of age-sex-
race/ethnicity specific PAFs allows the estimation of gains in life expectancy without 
diabetes separately by sex and race/ethnicity.   
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To estimate hazard of death associated with diabetes, I fitted Cox proportional 
hazard regression models with duration since baseline as exposure time using data 
from the 1997-2009 NHIS-LMF. The outcome was death from all causes during the 
follow-up period. The analysis of this chapter was limited to adults aged 30 and older. 
Among 294,936 adults, 7,856 (or 2.7%) were excluded from analyses due to missing 
information on covariates. In addition, those with less than one quarter-year of follow-
up were also excluded (n=270), yielding a final sample of 286,810 adults. I limited 
follow-up to a maximum of 5 years following the survey date in order to reduce the 
possible bias that individuals were diagnosed with diabetes after they were surveyed. 
Proportional hazards assumption was tested based on the slope of the Schoenfeld 
residuals for the model.  
1.4.2 Variable Definitions 
Diabetes was identified based on self-reported diagnosed diabetes in the NHIS. 
During the interview, NHIS respondents were asked “Other than during pregnancy, 
have you ever been told by a doctor or health professional that you have diabetes or 
sugar diabetes.” If answered “yes” to the question, I assigned them as diabetic. Those 
who answered “no” or “borderline diabetes” were considered as non-diabetic. Other 
covariates include age, gender, race/ethnicity, educational attainment, and smoking. 
Age is baseline age at the survey. Race/ethnicity was constructed by self-reported 
identification and categorized as non-Hispanic Whites (reference category), non-
Hispanic Blacks, Hispanics and other racial/ethnic groups. Education was categorized 
into four groups: less than 9th grade, 9th – 11th grade, high school graduate (reference 
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category), some college and 4 years of college degree or higher. Smoking was 
categorized as never (reference category), former smoker and current smoker. 
Respondents were asked whether they had ever smoked 100 cigarettes in their entire 
lifetime. If they reported “no” to the question, I assigned them as never smoker. If they 
said “yes” to the question, but were currently not smoking, they were considered 
former smokers. Current smokers are those who reported that they are currently 
smoking. Drinking is categorized as never drinker, former drinker and current drinker. 
Former drinkers are those who did not drink during the past year, but had more than 
100 drinks in lifetime. Current drinkers are people who had more than one drink in the 
past year. Hypertension is self-reported, constructed using a survey question asking 
whether respondents were diagnosed with hypertension or high blood pressure by a 
doctor or other health care professional. 
1.4.3 Statistical Approach 
To estimate the risk of death associated with diabetes, three Cox Proportional 
models were used. In the first model, all covariates- race/ethnicity, self-reported 
diagnosed diabetes, age at baseline, male, education, smoking, drinking and 
hypertension- are adjusted for (Model 1). In Model 2, interactions between age at 
baseline and diabetes as well as between male and diabetes were additionally included, 
and race/ethnicity was dropped (Model 2). These variables in Model 2 are used to 
calculate age-specific hazard ratios for males and females, all racial and ethnic groups 
combined for 5-year age groups. Model 3 includes all variables in Model 2, 
race/ethnicity and interactions between diabetes and race/ethnicity. Based on results 
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from Model 3, age-sex-race/ethnicity specific hazard ratios associated with diabetes 
were calculated for 5-year age groups. For age category x to x+5, age of x+2.5 was 
used in the calculation of hazard ratios and 87.5 was used for the age group of 85+, 
that is the top age code in the NHIS. 
The prevalence of diabetes among deaths in each age-sex-race/ethnicity group 
was obtained from the 5-year follow-up in NHIS. The prevalence for age interval x to 
x+5 was based on the 5-year follow-up for cohorts aged x-5 to x+ 5 at baseline, a 
group whose exposure was centered on the age interval x to x+5. For instance, the 
prevalence in age interval 40-45 was calculated based on the number of individuals 
aged 35-45 at baseline and the number of deaths among them during the 5-year follow-
up. The PAF is defined as a function of the hazard ratio of death associated with 
diabetes and the prevalence of diabetes among those who died during the follow-up 
period: 
 
 
where pdi is the proportion of deaths occurring to those in exposure category i 
based on age, sex and race/ethnicity and HRi is the hazard ratio of death for an 
individual in the ith exposure category. The PAF values used in this chapter were 
estimated separately in 5-year wide age intervals. I assumed that the prevalence of 
diabetes among deaths for age intervals above 85 was constant and equal to the 
prevalence for the age category 85+.  Life expectancy after eliminating deaths from 
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diabetes was calculated from an associated single decrement life table for all causes 
other than diabetes (Preston, Heuveline, & Guillot, 2001). To do this, I first calculated 
age-sex-race/ethnicity specific PAF values based on corresponding hazard ratios and 
prevalence of diabetes among decedents obtained from the previous stages. Then, the 
proportion of deaths attributable to diabetes was eliminated from the 2010 US life 
tables at each age using the PAF values. Based on newly obtained age-sex-
race/ethnicity specific mortality rates in the life table, I reconstructed the life table 
using age-specific death rates without diabetes and calculated age-specific life 
expectancy.   
As discussed previously, the conventional way of estimating the impact of 
diabetes is to use an underlying cause of death. Because NHIS-LMF include 
information on underlying causes of death, it is possible to calculate the probability of 
dying without diabetes. Using this information, I then estimated life tables by sex and 
race/ethnicity without diabetes. I then compared these results to those based on the 
PAF approach (Table 1-7).  
Data analyses were performed using Stata version 15 (StataCorp, Texas, USA). 
All analyses incorporated sample weights and accounted for the complex design of the 
survey. Standard errors were estimated using the SVY routine.  
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1.4.4 Sensitivity Analysis 
After the primary analyses, I conducted multiple sensitivity analyses. For one, I 
estimated Cox Proportional regression models in which hypertension and drinking 
behaviors were omitted to assess the influence of these risk factors on the association 
between diabetes and mortality. In addition, I adjusted for BMI, a major risk factor for 
the development of diabetes to assess the effect of BMI on the prior results. In the 
main analysis, BMI was not considered due to the “obesity paradox,” which is the 
phenomenon that people with overweight/obese show lower mortality risk than those 
with normal weight when they have diabetes (Preston and Stokes, 2014). In a second 
sensitivity analysis, the 2005 official US life tables, instead of the 2010 life tables, 
were applied in to assess a potential bias derived from the selection of the year 2010 
for the US life tables.  
 
1.5 Results 
1.5.1 Descriptive Analysis 
Table 1-1 presents the demographic characteristics of the sample by sex and 
race/ethnicity. 286,810 individuals were included in analyses contributing a total of 
1,311,397 person-years. Compared to Whites, Blacks had higher and Hispanics had 
lower age-standardized death rates. Overall, death rates in participants with self-
reported diagnosed diabetes were higher than those of individuals without self-reported 
diabetes, but these differences were inconsistent across racial/ethnic groups. Overall, 
the prevalence of diagnosed diabetes in the sample was 8.9% among men and 8.4% 
 
19 
 
among women. As expected, Blacks and Hispanics had a higher prevalence of 
diagnosed diabetes than Whites for both men and women, which is consistent with the 
previous estimates from national statistics (CDC, 2017).    
1.5.2 Results from Cox Proportional Hazard Models 
Table 1-2 provides results from Cox Proportional hazards models. In Model 1, 
all covariates are adjusted for. As expected, Blacks (HR:1.141, 95% CI:1.086-1.199) 
had significantly higher hazard and Hispanics (HR:0.808, 95% CI:0.756-0.865) had 
lower hazard of death than Whites. Having diagnosed diabetes was significantly 
associated with mortality (HR:1.597, 95% CI:1.529-1.668). In addition, age, male, 
lower education, former and current smoking behavior and self-reported hypertension 
were significantly associated with a higher risk death.  
Model 2 additionally includes interactions between diabetes and age, and 
diabetes and male and drops race/ethnicity. The interaction between diabetes and age 
was significant (HR: 0.981, 95% CI: 0.977-0.985), implying that the risk associated 
with diabetes was reduced by a factor of 0.981 for each additional year of age beyond 
age 30. In addition, the interaction between diabetes and male was also significant 
(HR:0.889, 95% CI: 0.816-0.969), indicating that hazard of death for diabetic men was 
lower than that of diabetic women by a factor of 0.889.  
Model 3 introduces race/ethnicity and interaction terms between race/ethnicity 
and diagnosed diabetes. The interaction terms were significant for both Blacks 
(HR:0.793, 95% CI:0.697-0.902) and Hispanics (HR:0.828, 95% CI:0.711-0.963) and 
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hazard ratios of the interactions were less than 1. That is, the effect of diagnosed 
diabetes on all-cause mortality for Blacks and Hispanics were significantly weaker 
than that for Whites. Using the hazard ratios from Model 2 and 3, age-specific hazard 
ratios by sex and race/ethnicity were calculated and presented in Table 1-3. For 
example, a 50-year-old Black woman had a hazard ratio of 4.205*0.793*(.980)22.5 = 
2.450. 
1.5.3 The Prevalence of Diabetes among Deaths 
The prevalence of self-reported diagnosed diabetes among deaths is presented 
in Table 1-4 and graphically in Figure 1-1A. The overall prevalence among decedents 
is 22.8% among men and 22.5% among women, and these values are much higher than 
the prevalence of diabetes among the overall sample (8.9% among men and 8.4% 
among women). Figure 1-1A reveals a hill-shaped pattern for both sexes and three 
racial groups. In general, the prevalence increases rapidly with advancing age from age 
30-35 and then decreases sharply after ages around 75-79. There were little differences 
in the prevalence across race/ethnicity until ages 40-44 for both men and women, but 
then Blacks and Hispanics showed much higher prevalence than Whites. The racial 
gaps at older ages were greater among women than men: the prevalence at the age 
interval 65-69 were 27.0%, 29.4% and 36.4% for White, Black and Hispanic men, 
respectively, but for women the corresponding values were 26.5%, 43.5% and 51.1%.  
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1.5.4 Population Attributable Fraction 
Using age-specific hazards presented in Table 1-3 and prevalence of diabetes 
among decedents shown in Table 1-4, age-sex-race/ethnicity specific PAF values were 
calculated following the formula presented on page 16. Estimated PAF values are 
presented numerically in Table 1-5 and graphically in Figure 1-1B. Most importantly, 
three racial and ethnic groups had similar PAFs across ages. Such little variation is a 
product of lower hazard ratios for Blacks and Hispanics and their higher prevalence 
among deaths. For example, the ratio of White prevalence to Black prevalence among 
men in the age interval 55-59 is 0.71 (22.6/31.7), but the corresponding value for 
hazard ratios is 1.25 (2.117/1.697), resulting in a similar PAF for White (11.9%) and 
Black (12.8%) men at age 55-59 (Table 1-5). There were larger differences in the PAF 
values among women than men at older ages. This is because the observed excess 
prevalence of diabetes among Blacks and Hispanics compared with Whites was more 
prominent among women than men (Table 1-4 and Figure 1-1A).  
1.5.5 Gains in Life Expectancy from Eliminating Deaths from Diabetes 
Table 1-6 exhibits the gains in life expectancy at ages 30, 50 and 70 eliminating 
deaths attributable to diabetes using PAF and underlying cause of death. Based on the 
official 2010 US life table, life expectancy at age 30 in 2010 was 47.8 years for men 
and 52.0 years for women. Eliminating deaths attributable to diagnosed diabetes at 
each age interval increases life expectancy at 30 by 0.83 years for men and by 0.89 
years for women all racial combined. Hispanics have the smallest gain in life 
expectancy in both men (0.65 years) and women (0.80 years) at age 30 because they 
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have relatively lower death rates in the life tables especially at older ages in which 
PAF values are relatively high. Similar to PAF values presented in Table 1-4, I 
observed little differences in the gains in life expectancy by race/ethnicity in both 
sexes. This result is a product of the offsetting effects of higher prevalence of 
diagnosed diabetes among Black and Hispanic decedents and their lower hazard ratios 
associated with diabetes.  
Table 1-7 presents comparisons of gains in life expectancy and probability of 
dying at age 30 based on PAF and underlying cause of death. The gain in life 
expectancy for each sex from eliminating diabetes as an underlying cause of death was 
0.33 years at age 30, which is only about one third of the gain estimated based on 
PAFs. The value of 0.33 years is similar to a previous finding of 0.31 years of gain at 
age 30 in 1999-2001 reported by the NCHS (Arias, Heron and Teleda-Vera 2013). 
Similar patterns were present in the probability of dying from diabetes. At age 30, the 
probabilities were 0.055 for men and 0.062 for women per 1,000 persons when PAF 
values were applied, but the values were about a half for both sexes when based on 
underlying cause of death. Hispanic males and females show comparable gains in the 
life expectancy and higher probability of dying from diabetes based on underlying 
cause of death compared to estimated values based on PAF. For instance, the gain in 
life expectancy among Hispanic females based on PAF and underlying cause of death 
were the same at 0.80. In addition, with respect to probability of dying, the observed 
value based on an underlying cause of death is even higher than the probability of 
dying based on PAF among Hispanic males (0.050 vs 0.036) and females (0.070 vs 
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0.050) at age 30. This implies that diabetes is more likely to be assigned as the 
underlying cause on a death certificate of Hispanic decedents than other racial groups 
(Pandney et al. 2001).  
1.5.6 Results from the Sensitivity Analyses 
I conducted several sensitivity analyses as explained previously. First, when 
hypertension and drinking behaviors were dropped from the Cox proportional hazard 
models, the hazard ratio of diabetes increased and, in turn, gains in life expectancy 
without diabetes at age 30 rose from 0.83 years to 0.87 years for men and from 0.89 
years to 0.94 years for women. When BMI was included in Model 3 gains in life 
expectancy also increased at age 30 to 0.88 years for men and 0.98 years for women. 
These changes suggest that model specification affects the magnitude of the 
coefficients, but it does not seriously alter the interpretation of the results. In the 
second sensitivity analysis, I used the 2005 US official life table, instead of the 2010 
life table, and this transition slightly increased the estimated gain in life expectancy at 
age 30 by 0.02 years for both men and women because of higher age-specific mortality 
rates in the year 2005 compared to 2010.   
1.6 Discussion 
This chapter investigates the effect of diabetes on US life expectancy by 
applying age-sex-race/ethnicity specific PAFs to the 2010 US life tables. The 
elimination of deaths attributable to diabetes from the life table results in an increase of 
life expectancy by 0.83 years for men and 0.89 years for women at age 30. When 
 
24 
 
deaths listed diabetes as the underlying cause of death were deleted in the same 
fashion, the gain in life expectancy was only 0.33 years at age 30 (Table 1-7). The 
underestimation based on death certificates observed in this chapter is consistent with 
previous findings (Alegre-Díaz et al., 2016; Roglic et al., 2005; Stokes & Preston, 
2017). The overall PAF value in the sample was 7.2% for men and 8.4% for women 
aged 30 and over (Table 1-5). These values are slightly lower than the PAFs reported 
by Stokes and Preston (2017), which is 10.6% for men and 12.5% for women aged 30-
84, because this chapter includes ages 85 + and PAF values are found to decrease at 
older ages. Also, the estimated PAF values are higher than the probability of dying 
from diabetes (5.5% for men and 6.2% for women, Table 1-7), although both estimated 
PAF values and probability of dying are calculated based on the same set of age-
specific PAFs. The difference between two values are from difference in the age 
distribution of deaths between the US population and life table; the former is younger 
than the latter.  
Table 1-5 shows that three racial/ethnic groups have similar age-sex specific 
PAF values. The little variations in the distribution of age-specific PAFs are a product 
of higher prevalence of diabetes among Black and Hispanic decedents and lower 
hazard associated with diabetes for these groups compared to Whites. The lower 
hazard for racial minorities with diabetes than Whites are found in several studies that 
investigated all-cause and cause specific mortality (Conway et al., 2015; Conway, May, 
& Blot, 2012). However, questions remain why Blacks and Hispanics have lower 
hazard associated with diabetes. One possible explanation is that Blacks and Hispanics 
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who were diagnosed with diabetes may have a less severe case than Whites which led 
the racial minority groups to have lower risk of death than Whites when they have 
diabetes. This possibility was tested using the National Health and Nutrition 
Examination Survey (NHANES) 1999-2013 which has biomarker information for 
diabetes, such as glycated Hemoglobin (HbA1c). An analysis of HbA1c by 
race/ethnicity among NHANES adults ages 30 and over with self-reported diagnosed 
diabetes shows that the mean HbA1c is higher for Blacks and Hispanics than Whites, 
suggesting that this possibility is not the case. A second possibility is potential racial 
disparities in average glucose levels at a given HbA1c level. Previous studies reported 
that racial minorities tend to have lower fasting plasma glucose or 2-hr glucose levels 
than Whites at a given HbA1c (Wolffenbuttel et al., 2013; Ziemer et al., 2010). Thus, 
Blacks and Hispanics with self-reported diagnosed diabetes could have lower FPG or 
2-hr glucose than Whites (Davidson & Schriger, 2010; Guo et al., 2014) and therefore 
Blacks and Hispanics with diabetes could be at a lower risk of death due to lower 
glucose concentration than Whites with diabetes. A third explanation pertains to the 
relation between diabetes and mortality. The analysis of the current chapter is based on 
Cox Proportional hazard model that assumes that the relative risk of death from being 
diabetic is multiplicative rather than additive. However, the relationship could be 
additive rather than multiplicative (Mehta & Preston, 2016). If the relation is additive, 
Blacks who experience higher risk of death from other causes would have a higher 
absolute increase in mortality when being diagnosed with diabetes than Whites and 
Hispanics with diagnosed diabetes. However, Table 1-1 shows an opposite pattern; 
26 
Blacks showed a lower absolute increase in mortality with regard to being diabetic 
than Whites.  
This chapter has several limitations. First, identifying diabetes based on self-
reported diagnosed diabetes may not capture undiagnosed cases. However, a prior 
study reported that self-reported diabetes shows high sensitivity and specificity in 
detecting people with diabetes (Saydah et al., 2004). In addition, one paper that 
employed both a HbA1c measurement of 6.5% and self-reported diabetes in Cox 
proportional models reported very similar hazard ratios of death associated with 
diabetes for the two indicators (Stokes and Preston, 2017). Therefore, it is unlikely that 
the use of self-reports significantly affects the validity of the results. Second, the NHIS 
linked-mortality files do not include information on diabetes status during follow-up 
and it is possible that participants were diagnosed with diabetes during the follow-up 
period which could underestimate the impact of diabetes on mortality. To minimize 
this potential bias, all analyses were limited to the maximum of 5 years of follow-up 
beyond the survey. Lastly, this study pooled surveys from 1997 to 2009, nearly a 
decade, to increase sample size. Given considerable changes in the demographic 
composition of the US population and the prevalence of diabetes and mortality risks in 
people with and without diabetes during the last decade, it is possible that PAF values 
would be fluctuating during the period. However, secular changes in PAFs due to 
diabetes were not systematically tested in this study due to a small sample size.  
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TABLES 
Table 1-1. Sample Characteristics by Race/Ethnicity, Ages 30 and Above, NHIS-LMF 1997-2009 
 All Racesa Non- Hispanic White Non- Hispanic Black  Hispanic 
Men Women Men Women Men Women Men Women 
Death rateb 19.2 12.2 18.8 11.9 23.6 15.6 17.4 10.4 
    Among diabeticb 29.8 21.3 31.2 22.4 31.3 22.1 25.2 17.8 
    Among non-diabeticb 17.6 11.0 17.3 10.8 22.4 13.8 15.5 8.7 
Diabetes prevalence (%) 8.9 8.4 8.3 7.4 11.9 13.5 9.9 10.4 
Mean age (years) 50.7 52.2 51.9 53.4 48.6 49.8 45.9 47.5 
Age categories (%) 
    30-44 39.7 37.0 36.4 33.8 45.3 42.9 55.1 50.3 
    45-64  41.6 40.3 42.9 41.1 40.6 39.7 34.3 35.7 
    65 and over 18.7 22.7 20.8 25.1 14.1 17.4 10.6 14.0 
Education 
    Less than 9th grade 7.0 6.7 4.1 3.9 7.3 6.3 27.5 27.2 
 9th – 11th grade 7.6 8.0 6.5 6.7 11.5 13.0 12.9 12.9 
    High school graduate 30.8 32.8 31.2 33.8 36.4 33.6 27.3 27.5 
    Some college 25.7 28.0 26.5 29.0 27.8 30.2 19.6 20.3 
    4 Yrs college +  29.0 24.5 31.7 26.5 17.0 16.9 12.7 12.1 
Smoking 
     Never smoker 45.6 59.4 43.1 55.2 50.0 65.0 55.0 76.2 
     Former smoker 31.0 21.6 33.7 24.6 21.9 14.5 23.7 12.2 
     Current smoker 23.4 19.0 23.2 20.2 28.2 20.5 21.3 11.7 
Alcohol status 
     Never drinker 13.1 27.7 11.0 22.3 19.8 38.6 16.6 45.8 
     Former drinker 18.0 16.7 18.2 17.0 21.0 19.6 15.8 13.1 
     Current drinker 68.8 55.6 70.8 60.7 59.2 41.8 67.5 41.1 
Hypertension (% Yes) 30.7 31.7 31.4 31.0 37.1 43.8 21.1 26.0 
Number of deathsc 8,759 9,440 6,501 7,080 1,237 1,458 839 726 
Person-yearsc 565,675 745,722 389,327 496,118 68,274 110,793 85,425 112,159 
Unweighted N 124,272 162,538 85,367 107,956 15,215 24,351 18,617 24,258 
aAll races include other racial/ethnic groups that are not separately identified. 
bAge-standardized rates per 1,000 person-years using 2010 US population age distribution as the standard for both sexes. Source: 2010 US Census. 
cIndividuals in the sample are followed up to five years following the interview. 
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Table 1-2. Hazard Ratios from the Cox Proportional Hazard Model Predicting All-Cause Mortality, Ages 30 and Above, 
NHIS-LMF 1997-2011 
Model 1 95% CI Model 2 95% CI Model 3 95% CI 
Race/Ethnicitya 
   Non-Hispanic White (ref) 1.000 1.000 
   Non-Hispanic Black 1.141 [1.086-1.199] 1.217 [1.146-1.291] 
   Hispanic 0.808 [0.756-0.865] 0.848 [0.785-0.916] 
Diabetes 1.597 [1.529-1.668] 3.807 [3.170-4.574] 4.205 [3.483-5.076] 
Age (in years since age 30) 1.093 [1.091-1.095] 1.097 [1.095-1.099] 1.097 [1.095-1.099] 
Male 1.488 [1.435-1.542] 1.519 [1.458-1.582] 1.523 [1.462-1.587] 
Education 
    Less than 9th grade  1.229 [1.166-1.295] 1.200 [1.142-1.263] 1.235 [1.172-1.300] 
    9th – 11th grade 1.211 [1.147-1.278] 1.215 [1.152-1.282] 1.210 [1.147-1.278] 
    High school graduate (ref) 1.000 1.000 1.000 
  Some college 0.931 [0.886-0.979] 0.931 [0.886-0.979] 0.932 [0.887-0.980] 
    4 yrs college +  0.783 [0.738-0.830] 0.782 [0.738-0.829] 0.788 [0.743-0.835] 
Smoking 
    Never smoker (ref) 1.000 1.000 1.000 
    Former smoker 1.421 [1.364-1.482] 1.428 [1.370-1.488] 1.419 [1.361-1.479] 
  Current smoker 2.501 [2.374-2.636] 2.525 [2.340-2.661] 2.492 [2.365-2.623] 
Drinking status 
    Never drinker (ref) 1.000 1.000 1.000 
    Former drinker 1.036 [0.989-1.086] 1.046 [0.998-1.010] 1.037 [0.989-1.087] 
   Current drinker 0.710 [0.678-0.744] 0.716 [0.684-0.750] 0.715 [0.683-0.749] 
Hypertension 1.190 [1.146-1.237] 1.189 [1.145-1.234] 1.177 [1.133-1.223] 
Interactions with diabetesa 
    Diabetes X Age (in years since age 30) 0.981 [0.977-0.985] 0.980 [0.976-0.983] 
    Diabetes X Male 0.889 [0.816-0.969] 0.889 [0.815-0.969] 
    Diabetes X Non-Hispanic Black 0.793 [0.697-0.902] 
    Diabetes X Hispanic 0.828 [0.711-0.963] 
ref: Reference group.  
a “Other racial groups” are separately identified in Models 1 and 3, but results for this group are not shown. 
2
9
 
Table 1-3. Age-specific Hazard Ratios Associated with Diabetes, Ages 30 and Above, NHIS-LMF 1997-2011 
Age 
Interval 
All Races a Non-Hispanic White Non-Hispanic Black Hispanic 
Menb Womenb Menc Womenc Menc Womenc Menc Womenc 
30 – 34 3.224 3.625 3.549 3.993 2.815 3.167 2.938 3.306 
35 – 39 2.923 3.287 3.201 3.601 2.538 2.856 2.650 2.981 
40 – 44 2.650 2.980 2.886 3.248 2.289 2.576 2.390 2.689 
45 – 49 2.403 2.702 2.603 2.929 2.064 2.323 2.155 2.425 
50 – 54 2.179 2.450 2.348 2.641 1.862 2.095 1.943 2.187 
55 – 59 1.975 2.221 2.117 2.382 1.679 1.889 1.753 1.972 
60 – 64 1.791 2.014 1.909 2.148 1.514 1.704 1.581 1.778 
65 – 69 1.624 1.826 1.722 1.937 1.366 1.536 1.425 1.604 
70 – 74 1.472 1.655 1.553 1.747 1.231 1.386 1.285 1.446 
75 – 79 1.335 1.501 1.400 1.576 1.111 1.250 1.159 1.304 
80 – 84 1.210 1.361 1.263 1.421 1.002 1.127 1.045 1.176 
85 + 1.097 1.234 1.139 1.281     1.000 1.016 1.000 1.061 
aAll races include other racial/ethnic groups that are not separately identified. 
bHazard ratios are from Model 2 in Table 1-2. 
cHazard ratios are from Model 3 in Table 1-2. 
Age-specific hazard ratio is set to 1.000 if the value is lower than 1.000. 
In calculating age-specific hazard ratios, we used more decimal places than shown in Table 1-2. 
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Table 1-4. Prevalence of Diabetes (Percent) among Deaths, Ages 30 and Above, NHIS-LMF 1997-2011 
Age 
Interval 
All Racesa  Non-Hispanic White Non-Hispanic Black Hispanic 
Men Women Men Women Men Women Men Women 
30 – 34 2.5 3.9 4.0 6.4 1.9 1.3 0.0 0.0 
35 – 39 5.7 7.2 6.8 9.0 7.4 7.0 1.3 2.4 
40 – 44 10.3 9.6 9.0 11.0 18.5 7.9 6.4 8.8 
45 – 49 13.4 12.4 11.7 13.6 17.0 10.5 16.1 13.1 
50 – 54 17.8 20.0 15.2 19.7 24.6 23.4 20.1 15.9 
55 – 59 24.4 26.5 22.6 23.5 31.7 36.8 25.9 32.8 
60 – 64 28.7 28.4 28.0 23.8 31.2 39.4 36.6 47.9 
65 – 69 27.9 30.8 27.0 26.5 29.4 43.5 36.4 51.0 
70 – 74 27.2 30.1 26.0 26.7 28.3 44.8 34.8 41.3 
75 – 79 26.5 26.6 25.4 23.9 29.5 42.8 37.1 31.1 
80 – 84 22.8 22.0 21.8 19.4 27.1 38.8 35.3 31.8 
85 + 17.6 14.8 17.2 13.2 18.8 26.3 27.7 28.4 
Ages 30+ 22.8 22.5 22.0 20.1 26.0 33.7 27.2 31.0 
aAll races include other racial/ethnic groups that are not separately identified. 
The complex NHIS survey design is taken into account.  
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Table 1-5. Percentage of Deaths Attributable to Diabetes (PAF), Ages 30 and Above, NHIS-LMF 1997-2011  
Age 
Interval 
All Racesa  Non-Hispanic White Non-Hispanic Black Hispanic 
 Men Women Men Women Men Women Men Women 
30 – 34 1.7 2.8 2.9 4.8 1.2 0.9 0.0 0.0 
35 – 39 3.8 5.0 4.7 6.5 4.5 4.6 0.8 1.6 
40 – 44 6.4 6.4 5.9 7.6 10.4 4.8 3.7 5.5 
45 – 49 7.8 7.8 7.2 8.9 8.7 6.0 8.6 7.7 
50 – 54 9.6 11.8 8.8 12.2 11.4 12.2 9.8 8.6 
55 – 59 12.0 14.6 11.9 13.6 12.8 17.3 11.1 16.2 
60 – 64 12.7 14.3 13.3 12.7 10.6 16.3 13.4 21.0 
65 – 69 10.7 13.9 11.3 12.8 7.9 15.2 10.9 19.2 
70 – 74 8.7 11.9 9.3 11.4 5.3 12.5 7.7 12.8 
75 – 79 6.7 8.9 7.3 8.7 2.9 8.5 5.1 7.3 
80 – 84 4.0 5.8 4.5 5.8 0.0 4.4 1.5 4.8 
85 + 1.6 2.8 2.1 2.9 0.0 0.4 0.0 1.6 
         
Ages 30+ 7.2 8.4 7.4 8.0 6.6 9.4 6.7 9.5 
aAll races include other racial/ethnic groups that are not separately identified. 
We use age-specific hazard ratios (Table 1-3) and prevalence of diabetes among deaths (Table 1-4) with more decimal places than presented in tables. 
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Table 1-6. Life Expectancy at Ages 30, 50 and 70 in the 2010 US Life Table and Gains in Life Expectancy from Eliminating 
Deaths Attributable to Diabetes 
 2010 US Life Tablea Gain in Life Expectancy from Eliminating Diabetes 
 All NHW NHB Hispanic All NHW NHB Hispanic 
Men Men 
30 47.8 48.0 44.3 50.0 0.83 0.85 0.81 0.65 
50 29.6 29.7 26.6 31.4 0.77 0.80 0.70 0.61 
70 14.2 14.2 12.9 15.4 0.36 0.39 0.17 0.23 
Women Women 
30 52.0 52.2 49.5 54.6 0.89 0.85 1.05 0.80 
50 33.2 33.3 31.2 35.4 0.84 0.79 1.02 0.77 
70 16.4 16.5 15.8 18.0 0.47 0.46 0.44 0.37 
aSource: National Center for Health Statistics (2014). 
All: All racial/ethnic groups, NHW: non-Hispanic White, NHB: non-Hispanic Black. 
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Table 1-7. Comparison of Gains in Life Expectancy from Eliminating Diabetes and Probability of Dying from Diabetes at Age 
30: Population Attributable Fraction versus Underlying Cause of Death Calculations   
 Life Years Lost to Diabetes Using PAF Life Years Lost to Diabetes Using Underlying 
Cause of Death 
 All NHW NHB Hispanic All NHW NHB Hispanic 
Males 0.83 0.85 0.81 0.65 0.33 0.30 0.44 0.58 
Females 0.89 0.85 1.05 0.80 0.33 0.23 0.68 0.80 
 Probability of Dying from Diabetes  
using PAF 
Probability of Dying from Diabetes  
Using Underlying Cause of Death 
Males 0.055 0.059 0.044 0.036 0.027 0.025 0.033 0.050 
Females 0.062 0.061 0.060 0.050 0.028 0.022 0.053 0.070 
All: all racial/ethnic groups, NHW: non-Hispanic White, NHB: non-Hispanic Black 
 
 
 
 
 
3
4
 
FIGURES 
 
Figure 1-1. Prevalence of Diagnosed Diabetes among Deaths (Figure 1A) and Proportion of Deaths Attributable to Diabetes 
(PAF) (Figure 1B) by Sex and Race/Ethnicity at Ages 30 and Above, 1997-2011 NHIS-LMF. 
Age in the x-axis is the age at baseline. 
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CHAPTER 2  
 
THE EFFECT OF MEASURED AND DIAGNOSED 
DIABETES ON MORTALITY IN THE UNITED STATES 
 
Abstract 
Background: A strong association between diabetes and mortality is increasingly 
evident. Prior studies often ignored differences between self-reported diagnosed diabetes 
(self-reported diabetes) and biomarkers for diabetes measured at the start of the mortality 
follow-up (or at baseline). This chapter examines the mortality risks based on self-
reported diabetes and baseline HbA1c levels simultaneously.  
Data and Methods: Data are from the National Health and Nutrition Examination 
Survey (NHANES) 3 (1988-1994) and continuous NHANES 1999-2014, and Linked 
Mortality Files through December 2015. The NHANES sample adults ages 30-84 
(n=40,103) are categorized by a baseline HbA1c cutoff point of 6.5% and further by self-
reported diabetes, resulting in four diabetes groups: HbA1c < 6.5% and without self-
reported diabetes (no diabetes);  HbA1c < 6.5% and with self-reported diabetes 
(controlled diabetes); HbA1c ≥ 6.5% without self-reported diabetes (undiagnosed 
diabetes); and HbA1c ≥ 6.5% and with self-reported diabetes (uncontrolled diabetes). 
Relative mortality risks among these four diabetes statuses are estimated using Royston-
Parmar survival models.  
Results: Results from survival models show that self-reported diabetes has a stronger 
association with mortality than baseline HbA1c. In all models, adults with self-reported 
diabetes (either controlled diabetes or uncontrolled diabetes) have a higher mortality risk 
than adults without self-reported diabetes (either no diabetes or undiagnosed diabetes). 
Thus, the results show that adults with self-reported diabetes have a higher risk of death 
than those without self-reported diabetes, regardless of their diabetes status identified by 
baseline HbAlc.  
Conclusion: When considered simultaneously, self-reported diabetes shows a stronger 
predictive power for mortality than baseline HbA1c. Therefore, public health 
interventions for diabetes prevention should focus on people who at a risk of developing 
diabetes and those whose HbA1c level indicates prediabetes and those with diabetes 
regardless of their HbA1c level.  
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2.1 Introduction 
Diabetes mellitus is one of the leading causes of death and public health threats 
in the United States. Previous evidence has consistently shown that people with 
diabetes/prediabetes have higher risks of a wide range of complications, including 
cardiovascular diseases, cancer, stroke, acute myocardial infarction, major amputations 
and kidney damage than people without the disease (Morgan et al., 2000, Center for 
Disease Control & Prevention, 2011; Seshasai et al. 2014). Furthermore, it has also 
been well documented that people with diabetes are at a higher risk of all-cause and 
specific-cause mortality than those without diabetes (Alegre-Diaz et al., 2016; Fox, 
Sullivan, D’Agostino, & Wilson, 2004; Saydah, Tao, Imperatore, & Gregg, 2009; 
Seshasai et al., 2014; Shen et al., 2014; Stokes & Preston, 2017). Recent studies have 
also reported that diabetes is responsible for about 11.7% of total deaths (Stokes & 
Preston, 2017) and a reduction of 0.86 years of life expectancy at age 30 in the United 
States in 1997-2009 (Preston, Choi, Elo and Stokes, 2018).  
In studies using prospective cohorts, the relative risk of death between people 
with and without diabetes has been estimated using either a biomarker for diabetes, 
such as fasting plasma glucose (FPG), measured at the start of mortality follow-up (at 
baseline, hereafter) or self-reported diagnosed diabetes (self-reported diabetes, 
hereafter), depending on a research design or data availability. These two 
measurements are often used as interchangeable alternatives in the literature without 
recognizing differences between the two measurements. In this chapter, I argue that 
self-reported diabetes and baseline biomarkers for diabetes at baseline are not identical 
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in terms of the time of the measurement and characteristics of the disease in relation to 
mortality risk.  
Using a nationally representative sample, this chapter examines the risk of 
death associated with diabetes by using both self-reported diabetes and baseline 
HbA1c. By doing so, this chapter will contribute to the literature by suggesting an 
alternative method of classifying diabetes status in studies of diabetes and mortality. 
Furthermore, the simultaneous use of both self-reported diabetes and biomarkers will 
answer the following important questions: how does the mortality risk vary among (1) 
persons who have never been diagnosed with diabetes; (2) those who are able to 
control their high blood glucose levels; (3) people with undiagnosed diabetes; and (4) 
individuals with diabetes who have not been able to control their diabetes?  
 
2.2 Literature Review 
2.2.1 Biomedical Indicators for Diabetes and Mortality  
Diabetes is a combination of diverse metabolic disorders resulting from chronic 
hyperglycemia with dysfunction of insulin secretion and/or insulin action (American 
Diabetes Association 2010). Diabetes occurs when the pancreas does not produce 
enough insulin that converts sugar inside the cells into energy or insulin in the body 
cannot be properly used. People with diabetes are unable to regulate a blood sugar 
level which leads to high glucose concentration and development of vascular 
complications. Health providers typically diagnose diabetes through assessing the 
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amount of sugar in blood, for instance, based on FPG and 2-hr glucose concentration 
during an oral glucose tolerance test (OGTT).  
Recently, HbA1c test has been recommended for screening and diagnosing 
diabetes by the American Diabetes Association (ADA) and International Expert 
Committee because of its distinct advantages over the traditional diagnostic strategies, 
especially measures of plasma glucose (Hussain, 2016). The term HbA1c refers to 
hemoglobin that binds with glucose in blood cells. A level of HbA1c – the percentage 
of glycated hemoglobin relative to total hemoglobin – indicates an average level of 
plasma glucose that sticks to the blood cells over a two to three months period. The 
ADA, International Expert Committee and WHO recommended the use of a HbA1c 
value of ≥ 6.5% for a diagnostic criterion for diabetes and HbA1c levels between 5.7% 
and 6.4% for a diagnostic criterion for prediabetes (ADA, 2010; International Expert 
Committee 2009).  
The most prominent advantages of HbA1c relative to other glycemic indices 
are its high repeatability, reliability, little intra-person variation, day-to-day variability 
of glucose levels and availability during non-fasting state (International Expert 
Committee, 2009; Bonora & Tuomilehto, 2011). In particular, when compared to FPG 
or 2-hr OGTT that assess blood sugar concentration at a moment of a single day, 
HbA1c appears to better measure chronic-hyperglycemia for the previous 120 days and 
to be less affected by various factors at the examination, such as fasting status, 
providing more reliable information on blood glucose levels (Davidson, Peters, 
Schriger 1995; Adams et al., 2009; Guo, Moellering, & Garvey, 2014). In addition, 
studies reported that HbA1c shows better explanatory power for mortality compared to 
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FPG and 2-hr OGTT (Bancks et al 2014; Selvin 2005). Due to these advantages, 
HbA1c test has been strongly advocated for diagnosing diabetes and early detection 
and management of diabetes (Gallagher, Le Roith, & Bloomgarden, 2009). 
Using HbA1c as the main diabetic diagnostic test, a body of literature has 
consistently demonstrated that increasing HbA1c is strongly associated with an 
increased risk of mortality (Lazzeri et al., 2015; Saydah, Gregg, Kahn, & Ali, 2018; 
Saydah et al., 2009). A study by Saydah et al. (2009) analyzed adults ages 20 and older 
using NHANES III and found that adults with HbA1c levels ≥ 8% had higher risks of 
mortality from all-cause (HR:2.6, 95% CI:1.9-3.6), heart disease (HR:3.4, 95% CI:2.0-
5.8) and cancer (HR:2.4, 95% CI:1.2-6.0) compared with adults with HbA1c levels < 
6%, net of potential confounding factors. In a study of 7,388 Singapore Chinese adults 
conducted by Bancks et al. (2017) also found that HbA1c levels ≥ 6.5% were 
significantly associated with mortality from all-cause, CVD, cerebrovascular and 
cancer diseases when compared to HbA1c levels 5.4%-5.6%, net of demographic 
characteristics and health behaviors (Bancks et al., 2017). The same findings were 
reported from studies that adopted the HbA1c cut point ≥ 6.5% as a definition of 
diabetes (Stokes and Preston 2017; Stokes and Mehta 2013).   
On the other hand, several studies reported a nonlinear relationship between 
HbA1c levels and excess death (Bancks et al., 2014; Carson et al., 2010; Palta, Huang, 
Kalyani, Golden, & Yeh, 2017). For instance, Selvin et al. (2011) found a significant 
association between HbA1c and excess death in HbA1c levels equal to or greater than 
5.5%, but there was an inverse relationship below HbA1c level of 5.5%, resulting in a 
J-shaped pattern. Saydah et al. (2009) also found a similar pattern; all-cause mortality 
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decreases as HbA1c increases at HbA1c levels below 5%, but there was a strong 
relationship between HbA1c and mortality at HbA1c levels ≥ 6% (Saydah et al., 2009). 
The J-shaped, or sometimes U-shaped pattern, was also observed with FPG 
(Sreenivasa et al., 2011). Although the inverse relationship between elevated HbA1c 
and mortality was observed at diverse HbA1c thresholds, but these were mostly on the 
left tail of HbA1c distribution, suggesting that the inverse pattern perhaps is related to 
characteristics of people with very low levels of HbA1c. One possible explanation for 
this phenomenon is that people with low HbA1c also have low body weight and low 
cholesterol and experience malnutrition, functional decline and other comorbidities, 
which are associated with higher risk of mortality (Abdelhafiz & Sinclair, 2015).  
 
2.2.2 Self-reported Diagnosed Diabetes and Mortality 
Along with HbA1c and plasma glucose indicators, many prospective cohort 
studies have used self-reported data to identify diabetes status using nationally 
representative survey (Alegre-Díaz et al., 2016; Gregg, Gu, Cheng, Venkat Narayan, & 
Cowie, 2007; Oba, Nagata, Nakamura, Takatsuka, & Shimizu, 2008; Shen et al., 
2014). For instance, NHIS collects data on participants’ diabetes by asking the 
question “Have you ever been told by a doctor or health professional that you have 
diabetes or sugar diabetes?” Also, the Behavioral Risk Factor Surveillance System ask 
a similar question of “Has a doctor, nurse, or other health professional ever told you 
that you had any of the following?” Studies commonly assign participants who 
answered “yes” to these questions as diabetic and compare them with those who 
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answered “no” to assess relative risk of mortality between participants with and 
without diabetes.  
Although less precise compared to biomarkers, prior evidence shows high 
sensitivity and specificity of self-reported diabetes. A review paper by Saydah et al. 
(2003) reported that self-reported diabetes used in earlier studies showed a level of 
sensitivity ranged from 70% to 99% and specificity from 92% to 99% (Saydah et al., 
2004). Schneider et al. (2012) also showed relatively high sensitivity and specificity of 
self-reported diabetes; for prevalent diabetes, the sensitivity of self-reported diabetes 
ranged from 58.5% to 70.8% and specificity ranged from 95.6% to 96.8% (Schneider, 
Pankow, Heiss, & Selvin, 2012). The high sensitivity and specificity of self-reported 
diabetes is attributable to substantial improvement in diabetes screening, clear 
diagnostic criteria for diabetes and increasing attention to diabetes epidemic in recent 
years (Midthjell et al 1992; Cricelli et al. 2003).  
Based on self-reported diabetes, many studies have estimated relative risk of 
mortality associated diabetes (Luk et al., 2016; Saydah et al., 2009; Stokes & Preston, 
2017). Although these associations vary depending on the study populations, previous 
studies found comparable associations between self-reported diabetes and mortality. 
For instance, Gregg et al. (2018) reported a relative risk of all-cause death associated 
with self-reported diabetes ranges from 1.6 to 2.0 during 1988 – 2015 with adjustment 
for age, sex and race/ethnicity. One study conducted in Hong Kong by Shen et al. 
(2014) showed a similar relative risk of 1.56 after adjusting for several 
sociodemographic and health behavioral characteristics. Oba et al. (2009) reported a 
value of 1.35 for the relative risk of having self-reported diabetes compared to not 
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having diabetes in Japan after adjustment for basic demographic characteristics, 
physical activity, hypertension and dietary.  
Note that these values are not only comparable between studies that used self-
reported diabetes, but also among studies that focused on the HbA1c criteria (Saydah 
et al., 2009a; Selvin et al., 2010; Shen et al., 2014; Stokes & Preston, 2017). In other 
words, the direction and magnitude of effects of diabetes on mortality observed in the 
previous studies appeared to be similar when diabetes is identified based on self-
reported diabetes or a baseline HbA1c level. For instance, Stokes and Preston (2017) 
estimated the effect of diabetes on mortality using self-reported diabetes from NHIS 
1997-2009 and a HbA1c cutoff of 6.5% from NHANES 1999-2010. Reported hazard 
ratios of death associated with diabetes were very similar at 2.00 for self-reported 
diabetes and 1.88 for the HbA1c criterion (Stokes & Preston, 2017).  
 
2.2.3 The Effect of Measured and Diagnosed Diabetes on Mortality  
As seen in the review of the literature, researchers have found similar 
associations between diabetes and mortality when diabetes is identified by self-reports 
and baseline HbA1c. Furthermore, there has been little studies that investigated 
different aspects of the two indicators in estimating mortality risk associated with 
diabetes. Thus, most studies tend to simply classify people into a diabetic or non-
diabetic group based on either self-reported diabetes or the level of HbA1c (Brancati et 
al., 1996; Saydah et al., 2009a), using the two measurements interchangeably.  
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However, different characteristics of self-reported diabetes and baseline 
biomarkers of diabetes have been recognized and used, especially in studies of 
undiagnosed diabetes. In other words, researchers typically combine information on 
individuals’ self-reported diabetes and baseline FPG or HbA1c to identify undiagnosed 
diabetes (Gregg et al., 2004; Menke, Casagrande, Geiss, & CC, 2015). In their paper 
on undiagnosed diabetes, for instance, Young and Mustard (2001) mentioned that 
“Undiagnosed diabetes can only be detected in a survey or screening setting when 
individuals are tested for plasma glucose levels and are asked about a past history of 
physician-diagnosed diabetes” (Young & Mustard, 2001, p24). Following this 
approach, previous studies assigned individuals as having undiagnosed diabetes when 
the individuals meet the clinical criteria for diabetes, such as HbA1c ≥ 6.5% or FPG ≥ 
126mg/dL, but have not been previously diagnosed with diabetes (Menke, Casagrande, 
Avilés-Santa, & Cowie, 2017; Selvin, Wang, Lee, Bergenstal, & Coresh, 2017). 
Specifically, researchers first investigate baseline diagnostic biomarker for diabetes to 
determine whether or not individuals have diabetes. Then the researchers further 
classify the individuals based on self-reported diabetes to determine whether diabetes 
was previously diagnosed. As such, using both measurements with a recognition of 
differences between the two indicators provides more insights than when only one of 
the two diabetes indicators is used. Nonetheless, this method has not been applied to 
research on mortality and diabetes.  
Yet, using both indicators is required to obtain a deep understanding of diabetes 
and mortality patterns given how diabetes is associated with mortality. People with 
diabetes often have associated complications and die from these complications 
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(McEwen et al., 2016). These complications and the deleterious effects of diabetes 
could be present with dysglycemia, even before a clinical diagnosis of diabetes is made 
and the harmful effect of the condition can last for many years without any symptoms. 
Therefore, it is important to consider accumulated damage caused by diabetes and the 
development and progression of long-term complications in order to better assess the 
association between diabetes and mortality.  
In this regard, using either self-reported diabetes or baseline HbA1c in a 
mortality study may provide insufficient understanding of the association between 
diabetes and mortality. Self-reported diabetes reflects patients’ hyperglycemic status in 
the past, the potential existence of complications and an accumulated negative health 
impact since the onset of diabetes. However, a previous diagnosis of diabetes does not 
guarantee the presence of diabetes and complications at the time of the survey, 
especially if the diagnosis was made in many years ago. In addition, self-reported 
diabetes could be affected by various factors, including a clinical definition of diabetes 
and a diagnostic test performed at the time of the diagnosis, access to healthcare 
services, a recall bias and so on. On the other hand, although baseline HbA1c may not 
capture the accumulated effect of diabetes and its complications that could have been 
present for many years before the survey. This is because baseline HbA1c can be 
affected by the recent use of diabetes medications (although these can be identified), 
lifestyle changes and patients’ diverse medical conditions at the time of blood testing 
(Nitin, 2010). Thus, it is more informative to use both measures at the same time, 
which allows to reflect accumulated damage from diabetes and also the current status 
of diabetes that would be associated with future mortality consequences.   
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In using both measurements, the time since the diagnosis of diabetes, or 
duration of diabetes plays a role. As discussed previously, the main difference between 
the two measurements is the time of the events. If a previous diagnosis of diabetes 
occurred right before the survey date in which a blood test is performed, the two 
indicators are basically identical, providing the same information. In addition, many 
studies reported that the duration of diabetes is positively associated with an increased 
risk of mortality (Banerjee et al., 2012; Brun et al., 2000; Creighton, Goldman, Pebley, 
& Chung, 2012). Therefore, I examined the role of the duration of diabetes on 
mortality to better explain how self-reported diabetes is associated with mortality, net 
of baseline biomarkers for diabetes.  
 
2.3 Aims of Chapter 2 
The main aim of this chapter is to estimate the mortality risk associated with 
diabetes by using both self-reported diabetes and an HbA1c threshold of 6.5% at 
baseline. In addition, I investigate the association between time since the diagnosis of 
diabetes and mortality based on self-reported diabetes.  
2.4 Data and Methods 
2.4.1 Data and Sample 
Data were obtained from the third National Health and Nutrition Examination 
Survey (NHANES) 1988-1994 and NHANES Continuous surveys 1999-2014. 
NHANES is a series of nationally representative surveys that include non-
institutionalized US population using a multistage stratified probability sampling 
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conducted by the National Center for Health Statistics (NCHS). NHANES participants 
were interviewed using a standardized survey questionnaire in their home and 
randomly selected participants aged 12 years or older subsequently received a physical 
and laboratory examination in a mobile examination center (MEC) where extensive 
medical data are collected. NHANES participants who were eligible for matching were 
linked to the National Death Index (NDI) based on a 14-item identification scheme. 
The NHANES participants who were eligible for the linkage with NDI were followed 
up mortality status from the survey date through December 31, 2015. All follow-up 
times were limited to a maximum of 5 years beyond the survey to minimize potential 
biases that survey participants without diagnosed diabetes at baseline become an 
incident case and HbA1c at follow-up can change during the follow-up period.  
I restrict the sample to individuals aged 30 - 84 at the time of the survey and 
who underwent both survey interview and medical examination from the NHANES 
MEC. Respondents aged 85 or older were excluded from analysis to reduce bias 
induced by mortality selection and an open-ended coding of 85+ in the continuous 
NHANES. In addition, survey sample with missing information on all covariates 
(n=6,011) or who died in the same month in which they were interviewed (n=7) are 
excluded. The resulting sample included 40,163 observations, and there were 2,633 
participants assumed to be deceased from all causes during 5-year follow-up.  
2.4.2 Variable Definitions  
The outcome is all-cause mortality identified in the Linked Mortality Files. 
Diabetes status is assessed by a combination of self-reported diabetes and a HbA1c 
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threshold of 6.5%. Self-reported diabetes is previously diagnosed diabetes constructed 
based on the question asking whether the respondent had ever been told by a doctor 
(NHANES III) or health professional (both NHANES III and continuous NHANES) 
that they have diabetes or sugar diabetes other than during pregnancy. If answered 
“yes” to the question, I assign them as diabetic. Those who answered “borderline” or 
“no” are considered as non-diabetic.  
HbA1c is used for a biomarker of diabetes following the American Diabetes 
Association. In the NHANES, hemoglobin fractions, including A1c, from specimens 
were collected and stored at the MEC and then analyzed at the University of Missouri-
Columbia (NHANES III and NHANES 1999-2000, 2001-2002, and 2003-2004) and 
the University of Minnesota Medical Center (NHANES 2005-2006, 2007-2008, 2009-
2010, 2011-2012, 2013-2014). There were changes in the laboratory instrument that 
processes HbA1c across NHANES surveys: HbA1c was performed on the Primus 
CLC330 in 1999-2004, the Tosoh A1c 2.2 Plus in 2005-2006 and the Tosoh A1c G7 in 
2007-2014. The assessment of internal and external laboratory quality controls was 
conducted to assess the effect of the changes in instruments on the distribution HbA1c 
using cross-over studies. There was no evidence that changes in laboratory method, 
survey design or population distribution affects the distribution of HbA1c across 
surveys (See online supplement1). Thus, I used HbA1c values without calibrating it, 
following the recommendation from the CDC. Based on most recent treatment 
                                                 
 
1 https://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/GHB_G.htm 
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guidelines suggested by the American Diabetes Association, participants with a HbA1c 
a HbA1c threshold of 6.5% is used to identify diabetes (ADA, 2009).  
Based on self-reported diabetes and the HbA1c cut point of 6.5%, the sample 
adults are categorized into four groups: (1) no diabetes for participants with HbA1c < 
6.5% and without self-reported diabetes; (2) controlled diabetes for participants with 
HbA1c < 6.5% and with self-reported diabetes; (3) undiagnosed diabetes for 
participants with HbA1c ≥ 6.5% and without self-reported diabetes; and (4) 
uncontrolled diabetes for participants with HbA1c ≥ 6.5% and with self-reported 
diabetes.  
Previous studies often treat participants as diabetic if the participants are using 
medications or insulin even though they do not meet the biomedical criteria of 
diabetes, because only those who were diagnosed with diabetes are assumed to take 
these medications (Stokes & Mehta, 2013; Stokes & Preston, 2017). Individuals with 
HbA1c levels below and above 6.5% could be taking medications if they had been 
previously diagnosed with diabetes. In this study, I do not consider taking diabetes 
medications in categorizing diabetes status in this chapter. In addition, the current 
chapter does not distinguish between type 1 and 2 diabetes because NAHNES does not 
collect information on types of diabetes. However, type 2 diabetes accounts for more 
than 90% of all diabetes cases (National Diabetes Statistics 2017) and, therefore, 
results from this chapter are more likely to be associated with type 2 diabetes. 
The covariates are grouped into three categories: sociodemographic 
characteristics, health behaviors, diabetes complications. Sociodemographic 
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characteristics include age at baseline, sex, race/ethnicity, and education. Age at 
baseline is treated as continuously. I categorize educational attainment as less than 9th 
grade, 9th – 11th grade, high school graduate, some college and 4 years of college 
degree or higher. Race/ethnicity is categorized as non-Hispanic whites, non-Hispanic 
blacks, Hispanics and other racial/ethnic groups based on self-identification. Health 
behaviors include smoking behavior and drinking use, BMI and having access to 
healthcare services. For drinking status, I categorize it as never drinker, former drinker 
and current drinker. Former drinkers are those who did not drink during the past year, 
but had more than 100 drinks in lifetime. Current drinkers are people who had more 
than one drink in the past year. Smoking behavior is categorized as never smoker, 
former smoker and current smoker. BMI is measured at baseline and used as a 
continues variable. Having access to health care is a binary variable constructed based 
on a survey question asking whether participants have a place (or more than one place) 
that they usually go when they are sick or need advice about their health. Diabetes 
related complications of interest are hypertension, hear failure, heart attack, stroke, 
kidney problems and activity limitations. All variables are binary and constructed 
based on self-reports by survey participants. Different survey questions for activity 
limitations are used for NHANES 3 and continuous NHANES 1999-2014. NHANES 3 
survey asked a question of “Have you ever changed your job, stopped working, or 
made any changes in your housework because of a disability or health problem?” On 
the other hand, continuous NHANES asked “Does a physical, mental or emotional 
problem now keep you from working at a job or business?” Although the questions are 
not identical, I code both as to having limitations versus no limitations. 
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The duration of diabetes is constructed based on self-reported age at the survey 
date and a NHANES survey question asking, “How old were you when a doctor or 
other health professional FIRST told you that you had diabetes or sugar diabetes?” The 
duration is then calculated as the participant’s age at the survey minus the age at the 
diagnosis. In regression models that examine the effect of duration of diabetes on 
mortality, participants who were diagnosed with diabetes 30 years prior to the survey 
year or longer were excluded (n=576 or 1.4% of the total sample) to obtain more 
reliable results.  
2.4.3 Statistical Approach 
In descriptive analysis, I calculate age-standardized death rates and prevalence 
of the six complications as well as weighted prevalence of other covariates by the four 
diabetes status groups defined above. A series of Royston-Parmar survival models are 
estimated to assess relative hazard of death from all causes and its 95% CI between the 
diabetes groups. While Cox Proportional Hazard model has been commonly used in 
prior mortality studies, this model assumes a proportionality of hazard. The Royston-
Parmar survival is flexible parametric survival model that flexibly fits the baseline 
hazard function on the proportional hazard scale at any time point in analysis. This 
feature allows to estimate an absolute impact of risk factors at all time points (Royston 
and Lambert, 2011) which is needed to calculate survivorships for the four diabetes 
groups during the follow-up. In a preliminary analysis, it is observed that hazard ratios 
estimated by Cox Proportional hazard and Royston-Parmar survival models are almost 
the same.  
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I specify three models: Model 1 adjusts for the four diabetes status groups, age 
at baseline, sex, race/ethnicity and education. Model 2 additionally controls for health 
behaviors that include smoking and drinking, BMI and not having access to healthcare. 
Model 3 further adds the six self-reported complications. In all models, no diabetes is 
the reference category. After fitting each of the three models, adjusted Wald tests are 
conducted to examine mortality differentials between the four diabetes groups.  
The effect of diabetes duration is estimated in Models 4 and 5. In these models, 
participants with self-reported diabetes, thus either with controlled diabetes or 
uncontrolled diabetes, are categorized into three groups by the duration of diabetes: 
less than 10 years, 10-19 years and 20-30 years. These groups are compared to 
participants without self-reported diabetes (either no diabetes or undiagnosed diabetes). 
Model 4 adjusts for the diabetes and duration status defined above and covariates used 
in Model 2. In Model 5, baseline HbA1c is additionally included.  
In all models, follow-up times are limited to a maximum of 5 years beyond the 
survey date to reduce a bias that could come from participants being diagnosed with 
diabetes or experienced changes in their HbA1c during the follow-up. All analyses 
account for the NHANES complex survey design and stratified multistage cluster 
sample using STATA 15 (StataCorp LP, College Station, Tx). 
2.4.4 Sensitivity Analysis 
Several sensitivity analyses are performed to assess the validity of results. In 
one sensitivity analysis, I use two additional cut points of HbA1c level of (1) ≥ 5.7% 
and (2) ≥ 7.0% in categorizing diabetes status to examine potential variation in results 
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due to different HbA1c thresholds. These specific cut points are selected to align with 
the guidelines of prediabetes (HbA1c levels between 5.7% and 6.4%) and sever 
hyperglycemia (HbA1c ≥7.0%) made by the American Diabetes Association (ADA 
2007). In a second sensitivity analysis, FPG is also used in combination with HbA1c; 
people with HbA1c ≥ 6.5% or FPG ≥ 126 mg/dl (or ≥ 7.0 mmol/L) or higher are 
considered as diabetic. Because information on plasma glucose were collected from 
participants who attended a MEC morning fasting session only, this sensitivity analysis 
is conducted among the restricted sample of 25,503.  
 
2.5 Results 
2.5.1 Descriptive Analysis 
Table 2-1 presents the characteristics of the sample by HbA1c ≥ 6.5% and self-
reported diabetes. Participants with no diabetes accounted for the majority of the 
sample (88.2%) and the proportion of participants with controlled diabetes (3.4%), 
undiagnosed diabetes (2.3%) and uncontrolled diabetes (6.0%) were relatively small. 
Higher age-standardized all-cause death rates (per 1,000 person-years) were 
distinguished by self-reported diabetes, rather than by the HbA1c criterion; death rates 
were 16.1 among those with controlled diabetes and 18.1 among those with 
uncontrolled diabetes, whereas much lower rates were observed for participants with 
no diabetes at 8.2 and undiagnosed diabetes at 10.1. The mean HbA1c was higher 
among individuals with undiagnosed diabetes (7.6%) and uncontrolled diabetes 
(8.2%) relative to individuals with no diabetes (5.4%) and controlled diabetes (5.9%). 
Participants with no diabetes were more likely to be a never smoker, current drinker 
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and have lower BMI than those in the other diabetes groups. The two groups with self-
reported diabetes (either controlled diabetes or uncontrolled diabetes) were much more 
likely to have access to healthcare than the other two groups without self-reported 
diabetes (either no diabetes or undiagnosed diabetes). Similar to the distribution of 
death rates, prevalence of six complications appeared to be higher among adults with 
self-reported diabetes than those without it and relatively small differences in the 
prevalence of complications were observed within the HbA1c criterion. For instance, 
self-reported hypertension was present in 60.9% among participants with controlled 
diabetes and 57.9% among those with uncontrolled diabetes, but percentages were 
lower at 31.8% and 46.9% among individuals with no diabetes and undiagnosed 
diabetes, respectively.  
2.5.2 Results from Royston-Parmar Regression Models 
Table 2-2 shows results from three Royston-Parmar survival regression models, 
expressed as hazard ratios with 95% confidence intervals. Model 1 shows that two 
groups with self-reported diabetes, individuals with controlled diabetes (HR:1.54, 95% 
CI: 1.33-1.78) and uncontrolled diabetes (HR:1.73, 95% CI: 1.56-1.93), had a 
significantly higher risk of death than the reference group, participants with no 
diabetes. However, there was a no significant difference between the reference group 
and those with undiagnosed diabetes (HR:1.01, 95% CI: 0.83-1.22). Age and being 
male were significantly associated with excess death. As expected, Blacks had a 
significantly higher hazard of death than Whites, whereas Hispanics and other racial 
groups had a significantly lower hazard.  
 
54 
 
In Model 2 in which smoking behavior, drinking status, baseline BMI and 
healthcare access are further included, there was little to no differences in the hazard 
ratios of the diabetes status compared to Model 1. The two groups with self-reported 
diabetes still had 61-85% higher hazard of death than individuals with no diabetes. In 
addition, the non-significant difference between individuals with no diabetes and those 
with undiagnosed diabetes observed in Model 1 remained. Being current and former 
smoker were significantly associated with excess death. Higher baseline BMI is 
associated with lower risk of death. This counterintuitive association between baseline 
BMI and mortality is consistent with prior studies that have shown a similar pattern, in 
contrast to when lifetime highest BMI is used (Carnethon, Rasmussen-Torvik, and 
Palaniappan, 2014; Stokes and Preston, 2017).  
Adjusting for the six self-reported complications in Model 3 reduced hazard 
ratios by 47.5% for controlled diabetes and 29.4% for uncontrolled diabetes. Despite 
the narrowing hazard of death, the two groups with self-reported diabetes (either 
controlled diabetes or uncontrolled diabetes) still had significantly higher mortality 
than respondents with no diabetes. Again, there was no significant difference between 
participants with no diabetes and those with undiagnosed diabetes in terms of 
mortality. Among the six complications, hypertension, heart attack, stroke and activity 
limitations were significantly associated with all-cause mortality. Hazard ratios of 
heart attack (HR:1.08, 95% CI:0.95-1.21) and kidney problems (HR:1.04, 95% CI: 
0.93-1.16) are higher than 1.00, but they are not statistically significant.  
Adjusted Wald tests are performed after fitting each of the models in order to 
compare hazard of death between the four diabetes groups (results are not shown). All 
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tests showed the same pattern. First, there was no significant difference between 
individuals with controlled diabetes and uncontrolled diabetes. Second, hazard of 
undiagnosed diabetes was significantly different from controlled diabetes and 
uncontrolled diabetes, indicating that respondents with undiagnosed diabetes had a 
significantly lower mortality risk than individuals with self-reported diabetes. These 
results suggest that adjusted hazard of death for adults with self-reported diabetes was 
significantly greater than that of adults without self-reported diabetes, regardless of 
their diabetes status based on baseline HbA1c.  
This observation is well described in Figure 2-1 that presents predicted 
survivorship by the four diabetes statuses during the 5-year follow-up. With advancing 
follow-up time, differences in survivorship between groups with and without self-
reported diabetes were increasing, whereas relatively small differences were found by 
the HbA1c criterion. In addition, individuals without self-reported diabetes (either no 
diabetes or undiagnosed diabetes) showed relatively higher survivorship over the 
follow-up period compared to those with self-reported diabetes (either controlled 
diabetes or uncontrolled diabetes). The two groups with self-reported diabetes 
experienced a sharp decrease in their survivorship and their probability of survival was 
lower than 0.9 at the end of the follow-up. 
A more conventional approach of testing the effect of diabetes on death is to 
use either HbA1c ≥ 6.5% or self-reported diagnosed diabetes. When these two 
indicators are estimated in separate models net of all covariates used in Model 3 (Table 
A1 in Appendix), both HbA1c ≥ 6.5% (HR:1.38, 95% CI:1.25-1.52) and self-reported 
diabetes (HR:1.49, 95% CI:1.36-1.64) were significantly associated with increased 
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hazard of death which is consistent with most previous findings (Stokes and Preston, 
2017).  
Table 2-3 presents the association between diabetes duration and mortality. The 
mean duration of diabetes at baseline among adults with self-reported diabetes was 
11.5 years (sd:0.83). Model 4 adjusts for all covariates used in Model 2. This model 
shows the significant effect of the duration of diabetes, such that, longer duration was 
associated with an increased risk of death. In Model 5 that further includes baseline 
HbA1c level, the significant effect of duration remains, although hazard ratios of 
duration were slightly reduced. In addition, there was a significant association between 
continuous HbA1c at baseline and mortality; each 1% increase in baseline HbA1c level 
increased hazard of death by a factor of 1.08 (Model 5, Table 2-3). 
2.5.3 Results from the Sensitivity Analysis 
Table 2-4 shows results from three sensitivity analyses. First, using HbA1c cut 
points of 5.7% (presented in Model 6) and 7.0% (presented in Model 7) did not 
significantly change results found in the previous models in which HbA1c ≥ 6.5% is 
applied, except for undiagnosed diabetes. One difference is that individuals with 
undiagnosed diabetes in Model 6 (HR:1.10, 95% CI: 1.01-1.21) and Model 8 
(HR:1.19, 95% CI: 1.01-1.40) had a significantly higher risk of death than those with 
no diabetes. This change found in Model 6 results from recategorizing participants 
whose HbA1c is between 5.7% and 6.4% from no diabetes into undiagnosed diabetes. 
People with an HbA1c level between 5.7% and 6.4% are considered as having 
prediabetes and people with prediabetes have been found to have an increased risk of 
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death compared to those with normoglycaemia in prior studies (Huang et al., 2016). 
Therefore, recategorizing these participants from no diabetes to undiagnosed diabetes 
results in increased relative risk of death for respondents with undiagnosed diabetes 
compared to respondents with no diabetes. A similar pattern is observed in Model 8. 
Participants with HbA1c <6.5%, but with ≥126 mg/dL are assigned as undiagnosed 
diabetes in Model 8, who are considered as no diabetes when the HbA1c criterion only 
is used. Because people with FPG ≥ 126 mg/dL are commonly considered as diabetic 
and these people are at an increased mortality risk, assigning them in undiagnosed 
diabetes in Model 8 results in the higher risk of mortality for this group compared with 
no diabetes. With regard to controlled diabetes and uncontrolled diabetes, there were 
no changes from the main results in these sensitivity analyses: these two groups still 
had a higher risk of mortality than the no diabetes group. Thus, the results from these 
sensitivity analyses indicate that the mortality risk of the undiagnosed group is 
sensitive to the way in which this group is defined. 
  
2.6 Discussion 
This chapter examines the mortality risk associated with diabetes by 
considering both baseline HbA1c and self-reported diabetes. When the two 
measurements were examined separately in a survival model, each indicator was 
significantly associated with an increased risk of death. However, the simultaneous use 
of these two measurements shows that the predictive role of self-reported diabetes on 
the risk of death is greater than that of baseline HbA1c (Table 2-2). Furthermore, 
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results show that adults with self-reported diabetes were at a higher risk of death than 
adults without self-reported diabetes, regardless of their diabetes status identified by 
HbA1c measured at baseline. 
Then why does self-reported diabetes show a stronger association with 
mortality than baseline HbA1c criteria? Explaining mechanisms for this finding is 
difficult from the cross-sectional data used in this study. However, the results from this 
chapter and previous studies suggest three possible explanations. First, Table 2-1 
exhibits that the mean HbA1c level was significantly higher in respondents with self-
reported diabetes than others without it within the same HbA1c categories, indicating 
that adults who were previously diagnosed with diabetes could have a more severe 
case. Likewise, the same table shows that the prevalence of six complications were 
more common among adults with self-reported diabetes than those without it within 
the HbA1c categories. Furthermore, it is observed that controlling for the six 
complications in Model 3 (Table 2-2) considerably reduces mortality gaps between 
adults with and without self-reported diabetes. These observations suggest that adults 
who were diagnosed with diabetes may have more deleterious health consequences of 
hyperglycemia for a longer period of time than those without self-reported diabetes. 
Therefore, there might be a selection of people with more conditions to the self-
reported diabetes category. These processes cannot be captured by baseline HbA1c 
measure alone.  
A second explanation is related to the duration of diabetes. The significant 
association between longer duration and increased mortality risk has been reported in 
earlier studies (Brun et al., 2000; Donaghue et al., 2003; Fox et al., 2004a; Valensi, 
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Pariès, & Attali, 2003) and is also observed in this chapter (Table 2-3). Adults with 
self-reported diabetes in the sample are also likely to have had diabetes longer than 
adults without self-reported diabetes. The estimated mean duration of diabetes among 
participants with self-reported diabetes was 11.5 years and it is less likely that adults 
with hyperglycemia have had the condition longer than 10 years without being 
diagnosed in the United States where the overall prevalence of undiagnosed diabetes 
has been found to be very low at approximately 0.8% - 1.4% (Selvin et al., 2017).     
Thirdly, the reverse relationship between HbA1c and mortality risk at lower 
levels of HbA1c could also contribute to the weak impact of HbA1c. As discussed 
previously, there is growing evidence showing that a J- or U-shaped pattern in the 
association between HbA1c and all-cause and CVD mortality (Abdelhafiz & Sinclair, 
2015; Palta, Huang, Kalyani, Golden, & Yeh, 2017). Therefore, ignoring an increased 
risk of death in the very low levels of HbA1c may underestimate the effect of having 
HBA1c level greater than 6.5%.  
This chapter also demonstrated that respondents with undiagnosed diabetes had 
a significantly lower hazard of death than respondents with controlled diabetes and 
uncontrolled diabetes. The lower hazard for individuals with undiagnosed diabetes 
compared with controlled diabetes group is especially interesting, given that the 
undiagnosed diabetes group is identified as diabetic at the beginning of the mortality 
follow-up by HbA1c, whereas the controlled diabetes group is considered as 
normoglycemic based on the same test. This finding is also somewhat contrary to the 
general understanding on undiagnosed diabetes; persons who are unaware of their 
diabetes tend to have serious health consequences because of delayed interventions 
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(Gregg et al., 2004; Menke et al., 2017). In addition, hyperglycemia has been found to 
be associated with an increased risk of comorbidities, including increased oxidative 
stress, vascular damages and cancer, among people without diabetes (Ceriello, 2008; 
Joshu et al., 2012; Su et al., 2008). However, the current findings suggest that being 
diagnosed diabetes through blood test does not necessarily result in a higher risk of 
death. This result is robust to the way undiagnosed diabetes is defined (Table 2-4).  
On the other hand, the risk of death for those with undiagnosed diabetes 
relative to those with no diabetes is sensitive to the way undiagnosed diabetes is 
defined. The results from the sensitivity analyses showed a significantly higher risk of 
death for undiagnosed diabetes relative to no diabetes with an additional consideration 
of those with HbA1c levels between 5.7% and 6.5% and FPG ≥ 126 mg/dL in the 
definition of diabetes. Yet, regardless of how undiagnosed diabetes was defined, 
participants with undiagnosed diabetes still had a lower risk of death than controlled 
diabetes and uncontrolled diabetes groups in all sensitivity analyses.  
The results from this chapter provide several important insights. First, the 
strong impact of baseline glycemic levels, HbA1c ≥ 6.5% or perhaps other biomedical 
indicators of diabetes on excess death reported in the previous literature could be a 
reflective of mortality differentials between people with and without a previous 
diagnosis of diabetes. Second, although several clinical randomized trials have 
reported the effectiveness of intensive medical therapy to control high blood sugar 
levels (Cheng et al., 2018; Zhang et al., 2017), it is unclear to what extent mortality 
risks at the population level can be reduced with such treatment. The current study 
shows that individuals who have been diagnosed with diabetes, regardless of whether 
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their disease is controlled, have an increased risk of death relative to those who have 
not been diagnosed with diabetes. Therefore, a public health intervention should focus 
on primary prevention that aims to reduce risk factors for the development of diabetes 
as well as target people with prediabetes. 
Several limitations of this study should be acknowledged. First and most 
importantly, the current chapter cannot explain how a previous diagnosis of diabetes is 
linked to baseline glycemic status and a subsequent mortality risk. The previous 
diagnosis of diabetes is expected to affect baseline HbA1c levels as people who were 
diagnosed with diabetes tend to control their blood glucose levels through various 
interventions which affects baseline HbA1c as well as mortality risk. However, since 
this study uses cross-sectional data, the mechanisms underlying the associations 
between self-reported diabetes, baseline HbA1c and mortality cannot be examined. 
Second, all diabetes related complications used in this chapter are self-reported which 
perhaps leads to an underestimation of the effect of these complications due to a 
measurement error. 
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TABLES 
Table 2-1. Sample Characteristics by HbA1c Cutoff of 6.5% and Self-Reported 
Diagnosed Diabetes. Adults Ages 30 – 84 at Baseline (n=40,103).  
HbA1c at baseline HbA1c < 6.5% HbA1c ≥ 6.5% 
Self-reported diabetes Undiagnosed Diagnosed Undiagnosed Diagnosed 
 No diabetes 
Controlled 
diabetes 
Undiagnosed 
diabetes 
Uncontrolled 
diabetes 
Unweighted N (%)a 33,780(88.2) 1,633(3.4) 1,437(2.3) 3,253(6.0) 
Person-years 151998.3 6893.7 6393.8 13685.8 
Number of deaths 1,850 209 116 447 
Death ratesb 8.2 16.1 10.1 18.1 
HbA1c level, mean (se) 5.4(0.01) 5.9(0.02) 7.6(0.05) 8.2(0.04) 
Duration of diabetesc - 9.6(0.4) - 12.6(0.3) 
Race/ethnicity     
    Non-Hispanic White 75.3 67.5 56.8 62.5 
    Non-Hispanic Black 9.2 13.5 17.3 16.1 
    Hispanic 10.3 12.3 16.8 14.6 
    Others 5.2 6.7 9.2 6.8 
Male  47.9 45.8 55.5 51.8 
Age at baseline (se) 50.5(0.1) 60.2(0.4) 58.0(0.5) 59.7(0.3) 
Educational attainment     
    Less than high school 17.3 25.6 30.5 30.4 
    High school 24.8 26.2 26.4 25.4 
    < 4 years college 28.2 28.8 28.5 29.0 
    4 years college + 29.8 19.4 14.6 15.1 
Smoking behavior     
    Never     50.6 46.4 46.6 49.2 
    Current smoker 22.0 15.7 19.0 17.1 
    Former 27.4 37.9 34.4 33.7 
Drinking status     
    Never  10.6 16.5 17.4 17.3 
    Former drinker 15.4 24.1 20.9 20.7 
    Current drinker 74.0 59.4 61.8 62.0 
BMI (se) in kg/m2 28.2 32.2 33.7 32.8 
Not having health care  12.8 2.0 13.3 3.6 
Complications (se)b     
   Hypertension 31.8 (0.4) 60.9 (2.1) 46.9 (2.2) 57.9 (1.5) 
   Heart failure  2.0 (0.1) 6.1 (0.6) 3.8 (0.6) 7.2 (0.6) 
   Heart attack 3.3 (0.1) 6.9 (0.7) 5.0 (0.6) 9.2 (0.8) 
   Stroke 2.4 (0.1) 7.2 (0.9) 2.9 (0.5) 5.5 (0.4) 
   Kidney problems 5.8 (0.2) 8.2 (0.9) 5.8 (0.8) 9.4 (0.9) 
   Limitations  10.5 (0.4) 25.8 (1.8) 15.7 (1.6) 20.8 (1.1) 
NHANES survey weight is accounted for. aPercentage in parentheses is weighted.  
bAge-standardized death rates using 2010 US population as the standard 
No diabetes: baseline HbA1c < 6.5% and without self-reported diagnosed diabetes 
Controlled diabetes: baseline HbA1c < 6.5% and with self-reported diagnosed diabetes 
Undiagnosed diabetes: baseline HbA1c ≥ 6.5% and without self-reported diagnosed diabetes 
Uncontrolled diabetes: baseline HbA1c ≥ 6.5% and with self-reported diagnosed diabetes 
cOnly among participants with self-reported diabetes  
Data source: NHANES III (1988-1994), Continuous NHANES 1999-2014 and LMF through December 31, 
2015.
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Table 2-2. Estimated Hazard Ratios from Royston-Parmar Survival Models. Adults Ages 30 – 84 at Baseline.    
 Model 1 95% CI Model 2 95% CI Model 3 95% CI 
Diabetes status       
   No diabetes (Ref) 1.00 1.00,1.00 1.00 1.00,1.00 1.00 1.00,1.00 
   Controlled diabetes 1.54 1.33,1.78 1.61 1.39,1.87 1.32 1.14,1.53 
   Undiagnosed diabetes 1.01 0.83,1.22 1.06 0.88,1.28 1.03 0.85,1.24 
   Uncontrolled diabetes 1.73 1.56,1.93 1.85 1.66,2.06 1.60 1.43,1.78 
Male 1.69 1.56,1.82 1.58 1.45,1.72 1.07 1.07,1.08 
Age at baseline, in years  1.08 1.07,1.08 1.08 1.07,1.08 1.57 1.44,1.71 
Race/ethnicity       
    Non-Hispanic White (Ref) 1.00 1.00,1.00 1.00 1.00,1.00 1.00 1.00,1.00 
    Non-Hispanic Black 1.11 1.00,1.23 1.09 0.98,1.21 1.08 0.98,1.20 
    Hispanic 0.76 0.68,0.85 0.79 0.71,0.88 0.81 0.72,0.91 
    Others 0.68 0.54,0.87 0.65 0.51,0.83 0.65 0.51,0.83 
Educational attainment       
    Less than high school (Ref) 1.00 1.00,1.00 1.00 1.00,1.00 1.00 1.00,1.00 
    High school  0.82 0.74,0.91 0.85 0.77,0.94 0.91 0.82,1.00 
    < 4 years college 0.73 0.65,0.82 0.77 0.69,0.86 0.84 0.75,0.94 
    4 years college + 0.52 0.46,0.60 0.58 0.51,0.67 0.69 0.60,0.79 
Smoking behavior       
    Never smoker (Ref)     1.00 1.00,1.00 1.00 1.00,1.00 
    Current smoker   2.05 1.83,2.30 1.85 1.65,2.08 
    Former smoker   1.32 1.20,1.45 1.26 1.14,1.38 
Drinking status       
    Never (Ref)   1.00 1.00,1.00 1.00 1.00,1.00 
    Former drinker   0.94 0.83,1.06 0.95 0.84,1.07 
    Current drinker   0.80 0.71,0.90 0.84 0.74,0.94 
BMI at baseline   0.98 0.97,0.99 0.97 0.96,0.98 
Not having usual health care    1.09 0.93,1.27 0.97 0.83,1.13 
Complications        
    Hypertension     1.17 1.07,1.27 
    Heart failure      1.94 1.72,2.19 
    Heart attack     1.08 0.95,1.21 
    Stroke     1.35 1.19,1.52 
    Kidney problems     1.04 0.93,1.16 
    Activity limitations      1.87 1.72,2.05 
NHANES survey weight is accounted for. Ref: Reference group.  
All models control for survey periods. 
Bold values are significant at the 95% confidence level.  
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Table 2-3. The Effect of Duration of Diabetes and Baseline HbA1c on All-cause 
Mortality (n=39,718).   
 Model 4 Model 5 
 HR 95% CI HR 95% CI 
Baseline HbA1c level  - - 1.08 1.04,1.12 
Diabetes status and durationa     
   No diabetes or Undiagnosed diabetesb  1.00 1.00,1.00 1.00 1.00,1.00 
   Less than 10 years 1.52 1.34,1.74 1.35 1.17,1.56 
  10-19 years 1.75 1.51,2.04 1.51 1.27,1.79 
  20-30 years 2.46 2.06,2.93 2.12 1.76,2.57 
a
Participants whose duration of diabetes is longer than 30 years are excluded.  
b
The reference group is participants without self-reported diabetes. 
All models include age at baseline, sex, race/ethnicity, education, smoking, drinking, BMI at baseline and 
access to healthcare. 
Bold values are significant at the 95% confidence level.  
NHANES survey weight is accounted for. 
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Table 2-4. Sensitivity Analysis: Using Different Criteria for Diagnosing Diabetes. Adults Ages 30 – 84 at Baseline.  
Model 6a Model 7b Model 8c 
Diabetes status HR 95% CI Diabetes status HR 95% CI Diabetes status HR 95% CI 
   No diabetes (Ref) 1.00 1.00,1.00    No diabetes (Ref) 1.00 1.00,1.00 No diabetes (Ref) 1.00 1.00,1.00 
   Controlled diabetes 1.60 1.23,2.06    Controlled diabetes 1.33 1.18,1.51 Controlled diabetes 1.84 1.27,2.65 
   Undiagnosed diabetes 1.10 1.01,1.21    Undiagnosed diabetes 1.20 0.92,1.57 Undiagnosed diabetes 1.19 1.01,1.40 
   Uncontrolled diabetes 1.56 1.40,1.74    Uncontrolled diabetes 1.69 1.50,1.91 Uncontrolled diabetes 1.71 1.51,1.93 
Ref: Reference group 
All models include all covariates adjusted for in Model 3 in Table 2-2. 
aParticipants with HbA1c ≥ 5.7% at baseline are assigned as diabetic.  
bParticipants with HbA1c ≥ 7.0% at baseline are assigned as diabetic.   
cParticipants with HbA1c ≥ 5.7% or FGP ≥126mg/dL at baseline are assigned as diabetic.  
For all models, those who are assigned as non-diabetic at baseline and with self-reported diabetes are labeled as controlled diabetes. 
For all models, those who are assigned as diabetic at baseline and without self-reported diabetes are labeled as undiagnosed diabetes. 
For all models, those who are assigned as diabetic at baseline and with self-reported diabetes are labeled as uncontrolled diabetes. 
cAn analysis is limited to a total of 25,359 adults who participated in a NHANES morning examination session.  
Bold values are significant at the 95% confidence level.  
NHANES survey weight is accounted for. 
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FIGURES 
 
 
Figure 2-1 Predicted Survival Curves during the Follow-up since the Survey Date by Self-reported Diabetes and HbA1c ≥ 6.5%.  
All estimates were calculated based on Model 3 in Table 2-2. 
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CHAPTER 3  
THE IMMIGRANTS HEALTH ADVANTAGE 
IN DIABETES IN THE UNITED STATES 
Abstract 
Background: Foreign-born immigrants have consistently been shown to have better 
health than the US-born. However, prior findings on diabetes have not been consistent. 
Most studies have relied solely on self-reported diabetes which could bias the prevalence 
of diabetes among immigrants downward due to immigrants’ limited access to healthcare. 
This chapter examines relative risks of diabetes between the foreign-born and the US 
native-born population by focusing on self-reported diabetes, biomedical indicators of 
diabetes and undiagnosed diabetes.  
Data and Methods: Data are from the National Health and Nutrition Examination 
Survey (NHANES) 3 and continuous NHANES 1999-2016. Three diabetes outcomes are 
used: self-reported diabetes, HbA1c ≥ 6.5% and undiagnosed diabetes. Multivariate 
logistic regression models are fitted to examine the relative risks of the three outcomes 
between the foreign-born and the US-born. In addition, associations between length of 
US residence and the three diabetes outcomes are examined. 
Results: The foreign immigrants were more likely to have self-reported diabetes (OR: 
1.28, 95% CI: 1.13-1.45) and HbA1c ≥ 6.5% (OR: 1.36, 95% CI: 1.22-1.51) compared 
with the US-born, net of age and sex. However, the foreign-born had lower odds of 
having self-reported diabetes (OR: 0.75, 95% CI: 0.64-0.88) and HbA1c ≥ 6.5% (OR: 
0.79, 95% CI: 0.69-0.91) after adjustment for race/ethnicity. After further adjusting for 
Body Mass Index (BMI), the foreign-born no longer had a significantly lower risk 
compared to the US-born. In all models, the foreign-born had greater odds of 
undiagnosed diabetes compared with their US-born counterparts. In addition, immigrants 
with < 15 years of US residence had an advantage in self-reported diabetes (OR: 0.76, 
95% CI: 0.61-0.95), but not in HbA1c ≥ 6.5% (OR: 0.91, 95% CI: 0.74-1.12) compared 
with US-born individuals.    
Conclusion: A racial/ethnic composition and BMI play a role in nativity disparities in 
diabetes. In addition, the foreign-born advantage in self-reported diabetes among those 
who have resided in the United States for less than 15 years is in part due to their higher 
prevalence of undiagnosed diabetes compared to that of the US-born.   
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3.1 Introduction 
Over the last three decades, immigrants residing in the US have continued to 
increase in size and as a proportion of the total US population. The number of the 
foreign-born was approximately 19.8 million in 1990, comprising 4.9% of the US 
population, but this number increased to 44 million by 2017, which accounts for nearly 
16% of the nation’s population (American Community Survey, 2017). The United States 
accepts more immigrants than any other country in the world and immigrants are coming 
from increasingly diverse origins, transforming the country to a more ethnically and 
racially diverse society. This rapidly growing size of the immigrant population implies 
that the health condition of immigrant population is of vital interest to the overall 
population health and public health system of the United States.  
To date, a body of literature has examined different health outcomes and 
behaviors of the foreign-born population in comparison with the native-born. The most 
pervasive finding in the literature is that foreign-born individuals in general have more 
favorable health outcomes than their native-born counterparts, even after adjusting for 
major sociodemographic characteristics (Hamilton, 2015; Kennedy, Kidd, McDonald, & 
Biddle, 2015). Although the better health of immigrants than native-born groups has been 
found with regard to a variety of health indicators, previous findings on diabetes have 
been inconsistent (Cunningham, Ruben, & Narayan, 2008).  
One limitation of the literature on diabetes is that most previous studies have 
solely used self-reported diagnosed diabetes (self-reported diabetes hereafter). However, 
using self-reported diabetes may not provide accurate estimates of actual relative risk of 
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diabetes between foreign-born and native-born individuals because of the former’s 
limited access to healthcare. With barriers in accessing health care services, immigrants 
are likely to have a lower chance of detecting their diabetes in the US, which could bias 
downward the prevalence of self-reported diabetes among immigrants relative to native-
born individuals.  
In this chapter, I aim to examine diabetes disparity between US-born and foreign-
born individuals with a special attention to self-reported diabetes as well as diabetes 
status measured based on biomedical indicators. The specific aims of this chapter are 
twofold. First, I examine the relative risk of diabetes among US immigrants compared 
with the native-born using self-reported diabetes, a measurement of HbA1c and 
undiagnosed diabetes. Using these outcomes allows me to examine whether and to what 
extent underreported cases of diabetes affects a difference in diabetes risk between the 
foreign-born and native-born Americans. Second, I examine the association between 
length of US residence and the three diabetes outcomes to examine potential variations 
among immigrants by time spent in the US.  
In the next section, I summarize studies of immigrant health and hypotheses for 
the favorable health outcomes of the foreign-born. I further describe these discussions in 
the context of diabetes and explain how using self-reported diabetes provides inaccurate 
estimates.   
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3.2 Literature Review 
3.2.1 The Health of Immigrants, and Diabetes 
Earlier research has consistently found that foreign-born individuals have lower 
mortality than native-born Americans (Abraído-Lanza et al. 1999; Sorlie et al. 1993; 
Borrell and Lancet 2012; Hummer et al; 1999a). These studies in general have found 
lower mortality rates among Hispanic subgroups over non-Hispanic Whites, and this 
mortality advantage that Hispanics enjoy is largely attributable to high percentages of 
foreign-born individuals among Hispanics (Borrell and Lancet 2012; Hummer et al; 
1999a). The lower risk of mortality among immigrants has also found in other 
racial/ethnic subpopulations, including Blacks and Whites (Singh and Siahpush, 2001; 
Singh and Siahpush, 2002).   
The health advantage of immigrants has also been observed with regard to some 
other major health indicators such as birth outcomes (Hummer et al., 1999b), 
overweight/obesity (Antecol and Bedard, 2006), cigarette smoking (Singh and Hiatt, 
2006) and disability (Cho and Hummer, 2001), although these advantages do not extend 
to all health indicators. For example, foreign-born individuals tend to report worse self-
reported health, mental health, occupational injuries, stomach and brain cancers and 
access to healthcare (Cunningham et al., 2008).  
Diabetes is also one of these exceptions; overall, studies of diabetes have found 
inconsistent or sometimes conflicting evidence. Many studies that analyzed nationally 
representative US samples reported different findings depending on race/ethnicity of 
study populations and confounding variables. One study that compared adjusted 
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prevalence of self-reported diabetes of the foreign-born to that of the US-born aged 18 or 
older found no significant difference between the two groups both in 1993 and 2003 
based on National Health Interview Survey (NHIS) waves 1993 and 2003 (Singh and 
Hiatt, 2006). However, based on 47,751 foreign-born and US-born blacks from NHIS 
waves 2000-2013, Ford, Narayan and Mehta (2015) reported that foreign-born blacks had 
a significantly lower prevalence of self-reported diabetes than their US-born counterparts, 
net of sociodemographic characteristics and smoking, but the advantage of the foreign-
born disappeared with an adjustment for BMI. Riosmena, Wong and Palloni (2013) who 
analyzed NHIS 1997-2007 waves also show that Mexican immigrants with <15 years of 
US residence were not statistically different from US-born Whites in terms of self-
reported diabetes. They also found that US-born Mexican Americans had a significantly 
higher odds of self-reported diabetes than US-born Whites (Riosmena, Wong and Palloni, 
2013). Different from these studies, one study conducted by Oza-Frank et al. (2013) 
observed that foreign-born Latinos had higher risks of incident diabetes (measured by 
fasting plasma glucose) than US-born Latinos, using a sample from the Multi-Ethnic 
Study of Atherosclerosis. 
However, studies that focused on certain geographic areas and subpopulations 
also reported contrasting findings. Foreign-born Asian Indians living in Atlanta, Georgia 
(Venkatraman et al. 2004), foreign-born blacks living in New York City (Horlyck-
Romanovsky et al., 2019) and foreign-born South Asians in New York City (Gupta, Wu, 
Young, & Perlman, 2011) have been found to have a higher prevalence of self-reported 
diabetes compared to US-born non-Hispanic whites or their US-born co-ethnic 
counterparts. One study of Beard et al. (2009) addressed that the prevalence of self-
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reported diabetes and diabetes-related complications has increased dramatically among 
Mexican Americans between 1993-1994 and 2004-2005 using data from the Hispanic 
Established Population for the Epidemiologic Study of the Elderly (Beard et al., 2009).  
These mixed findings may be attributable to many factors, such as different study 
populations, research designs and confounding variables. Among these factors, using 
self-reported diabetes for identifying diabetes might contribute to the heterogeneity. 
Although self-reported diabetes shows high sensitivity and specificity in identifying 
people with diabetes in a general population (Saydah et al., 2004), a misclassification 
issue could be critical when this measurement is used in assessing the prevalence of 
diabetes among immigrant populations. It is now well-documented that immigrants are 
vulnerable to inadequate healthcare access and have poorer healthcare utilization than the 
native-born due to immigrants’ lack of knowledge of US healthcare system and language 
proficiency (Derose, Escarce, & Lurie, 2007; McDonald, Manlove, & Ikramullah, 2009). 
For instance, previous studies have demonstrated that immigrants are less likely to 
participate in cancer screening (Snider, Beauvais, Levy, Villeneuve, & Pennock, 1996; 
Wong-Kim and Wang, 2006), more likely to have no health insurance coverage (Dey & 
Lucas, 2006; Trevino et al., 1991; Olveen et al., 2000), face lower quality of healthcare 
services (Elliott and Gillie, 1998; Feldman et al., 2009) and have fewer preventive and 
non-preventive doctor visits (Xu, 2005) than US-born natives. With regard to diabetes, 
prior evidence shows that diabetic immigrants are less likely to have health insurance 
coverage and a usual source of care than US-born individuals with diabetes (Dallo et al., 
2009). With infrequent visits to doctor and barriers to healthcare access, it is more 
difficult for immigrants to find out the onset of diabetes in the US or preexisting diabetes 
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that they brought from the country of origin. This lower chance of finding out diabetes 
would distort the prevalence of diabetes among immigrants in survey downward, which 
exaggerates their potential advantage in diabetes over natives. Therefore, relative risk of 
diabetes among immigrants compared with that among US-born Americans might be 
underestimated when researchers use only self-reported data. In addition, the extent to 
which estimates are underestimated may vary depending on sociodemographic 
characteristics of immigrants and how well they are incorporated into the US society, 
both of which are associated with the use of and access to healthcare.  
In the study of immigrant health, two major explanations have been proposed as 
pathways through which immigrants are in better health than their US-born counterparts: 
(1) health selection and (2) cultural buffering. These two explanations are also expected 
to provide a useful theoretical tool for a better understanding of nativity disparities in 
diabetes. In the following section, I review literature on the two hypotheses with a special 
attention to diabetes.  
3.2.2 Immigrant Health Selection and Diabetes 
Immigrant health selectivity operates in two ways through which immigrants 
have, on average, more favorable health status than natives; in-migration and out-
migration selection on health. In migration selectivity, or the “healthy migrant effect,” 
hypothesizes that those who are involved in international migration are not randomly 
selected people from their birth countries, instead they are likely to be healthier 
physically, psychologically and financially than non-migrants in the country of origin due 
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to self-selection and US screening of immigration (Crimmins et al., 2005; Jasso et al. 
2004).  
Similarly, out-migration selectivity, also known as the “salmon bias effect,” posits 
that the negative health selection into return migration occurs because unhealthy 
immigrants tend to return to their birth country, leaving only healthier immigrants in the 
receiving country (Turra and Elo, 2008; Palloni and Arias, 2004). In addition, there is 
mortality selection among less-healthy immigrants at older ages, thereby leaving 
healthier immigrants being observed in the US (Markides and Rote, 2018). Then both 
ways of selectivity leave more robust immigrants in the destination country, resulting in 
overall better health status of the immigrants compared with the nave-born population 
(Palloni and Morenoff, 2001). Prior studies that empirically examined the two hypotheses 
found the existence of the in-migration selection effect (Mehta & Elo, 2012; Cunningham 
et al., 2008), while a weak support for the out-migration selectivity (Turra and Elo, 
2008). 
People with diabetes often have diabetes complications and sometimes have 
serious illness and disability, such as blindness, that reduces their chance to undertake a 
taxing international US migration process. Thus, according to the selective migration 
hypotheses, immigrants would be expected to be less likely to have diabetes than both 
non-migrants in the country of origin as well as the overall population in the US (the 
healthy migrant effect). In addition, by the same token, people with diabetes in the US are 
expected to be more likely to return to their home country in order to have a better 
treatment with supports from family members (the salmon bias). Together, these 
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selection processes may give rise to a lower prevalent diabetes among immigrants 
compared with the native-born.  
However, the selection hypotheses perhaps operate differently with regard to 
diabetes due to the unique features of diabetes. First, diabetes often has an asymptomatic 
phase that could last many years (ADA, 2010), and people who are not aware of diabetes 
may decide to migrate without knowing that they have the disease. In this case, the 
people with diabetes ought to have the same chance of migrating as people without 
diabetes. Second, even though migrants are aware of diabetes, they may still decide to 
migrate to the US because diabetes can be controlled and managed with self-
administrated treatments and medications. Furthermore, people with known diabetes but 
without serious complications may not view the disease as a critical barrier that prevents 
them from moving to other countries for an important motivation, i.e., to find better job 
opportunities and family reunification.  
From the perspective of out-migration selectivity, it is also possible that people 
who have the disease in the United States may want to remain in the country, instead of 
returning to their birth country, if they find US healthcare system for treating diabetes to 
be better than in the country of origin.  
If these hypotheses are true, there would be no selection process in which people 
without diabetes are more likely to migrate and, therefore, there would be little 
theoretical ground to assume that US immigrants have a particularly lower risk of 
diabetes than the US-born. One study finds evidence supporting this idea; this study 
examined in- and out-migration selectivity in self-reported diabetes by comparing 
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Mexican immigrants living in the US and Mexicans living in Mexico with and without 
US migration experience. The authors found no significant difference in the risk of self-
reported diabetes between the two groups, suggesting that the two selection processes on 
self-reported diabetes are limited (Riosmena et al., 2013).   
In addition to these theoretical considerations, high prevalence of diabetes and 
undiagnosed diabetes in major US immigrant-sending countries can be another reason for 
a potential weak effect of the selectivity process. Mexico and India, two largest 
immigrants sending countries to the US for the last decade, showed age-standardized 
diabetes prevalence in 2014 to be 10.4% and 11.0%, respectively, among adults ages 20-
79, while the prevalence was 10.8% in the US in the same year (World Development 
Indicator, 2017). Furthermore, International Diabetes Federation reported that the 
prevalence of undiagnosed diabetes among people ages 20-79 in North American and 
Caribbean countries reaches 25.0% - 29.4% in 2013 (International Diabetes Federation, 
2013) and these estimates were comparable to that of the US (Selvin et al., 2017).  
Due to the nature of the explanations, the selection hypotheses can only be tested 
by comparing health outcomes of migrants living in the US, those who returned to the 
sending country and non-migrants in the same country (Riosmena et al., 2013). As such, 
several studies used binational data with which health of migrants, non-migrants and 
returned migrants can be compared (Bostean, 2013; Feliciano, 2005; Riosmena et al., 
2013). Unfortunately, this chapter uses the data that include US population only, making 
it impossible to test for the existence and magnitude of the emigration and return 
selection effects. Given the salmon bias effect, it could be that the risk of diabetes 
observed in foreign-born individuals is likely to be underestimated.  
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3.2.3 Cultural Buffering Effects  
Another major explanation for the immigrant health advantage pertains to cultural 
factors that affect favorable health behaviors, social support and family ties that have 
health protective effects for immigrants (Abraído-Lanza, Chao and Flórez 2005; Scribner 
1996). Researchers suggested that Hispanics’ favorable health behaviors of origin 
contribute to their lower mortality rates (Abraido-Lanza et al., 2006). Subsequently, the 
health protective effect of origin culture has also been observed in other racial/ethnic 
immigrant groups. Prior studies have shown that foreign-born individuals are less likely 
to engage in detrimental health behaviors such as smoking, drinking, and substance 
abuse, and tend to have healthier diet than their US-born counterparts, which offsets 
negative health effects from their lower SES (Abraído-Lanza et al. 1999; Palloni and 
Arias 2004).  
The effect of cultural orientation on health behaviors has been typically measured 
using a concept of acculturation, which is the process in which immigrants adopt the 
norms, attitudes and lifestyles of the destination country (Clark and Hofsess, 1998). 
Using this concept, much evidence shows that more acculturated immigrants tend to have 
more detrimental health outcomes than their less acculturated counterparts (Abraido-
Lanza, Chao, & Flórez, 2005), which has been referred to as a “negative acculturation 
effect.” For instance, immigrants with more US experience have been found to have 
higher risks of obesity (Antecol and Bedard 2006), unhealthy diet (Akresh 2007) and 
smoking and alcohol use (Cho et al 2004) compared with immigrants with lower levels of 
acculturation.   
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The literature on acculturation and health has several implications for the current 
study because some health behaviors, especially smoking and BMI, are important factors 
responsible for the development and progression of diabetes. If immigrants with lower 
levels of acculturation keep their protective health behaviors, i.e., healthy diet and non-
smoking behavior in the US, they are expected to have lower rates of diabetes than more 
acculturated co-ethnic groups as well as the native-born.  
However, studies have shown inconsistent evidence of acculturation and diabetes 
patterns. For instance, one study of 520 Arab Americans conducted in Dearborn, 
Michigan reported that lower acculturation was associated with higher risk of being 
dysglycemica (impaired fasting glucose, impaired glucose tolerance and diabetes) when 
acculturation was measured by various factors, including age at migration, consuming 
origin food, language use and integration into American society (Jaber et al, 2003). The 
same pattern was observed among Mexican Americans in Texas. Individuals with lower 
values on three measures of acculturation (functional integration with mainstream 
society, value placed on Mexican culture and attitude toward traditional family structure 
and sex-role organization) were associated with an increased risk of self-reported 
diabetes (Hazuda, Haffner, Stern, & Eifler, 1988). In contrast, other studies of Japanese 
(Fujimoto et al., 2000), Australian aborigines (O’Dea, 1991) and non-Mexican origin 
Hispanics (Kandula et al., 2008) showed a positive relationship between higher levels of 
acculturation and an increased risk of self-reported diabetes. One study that used diabetes 
medication, self-reported diabetes and fasting plasma glucose to identify diabetes 
exhibited insignificant effect of acculturation on the risk of diabetes among adults aged 
60-101 living in California’s Sacramento Valley (Afable-Munsuz et al. 2014). Using 
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different acculturation measurements (Lara et al., 2005) and a range of study populations 
(Cunningham et al. 2008) are likely to contribute to these mixed findings.   
3.2.4 Length of Residence and Diabetes 
Of many proxies for acculturation, duration of US residence is one of the most 
frequently used indicators in the literature on immigrant health (see a review paper done 
by Lara et al. 2005). Prior studies that used length of residence typically assumed that 
longer duration of stay is correlated with higher levels of acculturation. From this 
perspective, researchers posit that immigrants’ favorable health upon arrival erodes with 
additional years in the country, converging to native-born levels, as they adopt unhealthy 
lifestyles of the US population (Scribner 1996; Jasso et al., 2004). For instance, 
immigrants with longer duration of residence are more likely to be a current smoker and 
smoke more frequently than those who have spent less time in the country (Abraido-
Lanza et al., 2005; Gorman, Read, & Krueger, 2010; Kimbro, 2009). This negative effect 
of duration has been reported with alcohol consumption (Abraido-Lanza et al., 2005; 
Lopez-Gonzalez, Aravena, & Hummer, 2005), chronic conditions (Singh and Siahpush 
2002), high BMI or being overweight/obese (Antecol & Bedard, 2006; Bostean, 2013b), 
activity limitations (Cho, Frisbie, Hummer, & Rogers, 2004), allostatic load (Peek et al., 
2010), acculturative stress (Devylder et al., 2013) and self-reported health (Kimbro, 
Gorman, & Schachter, 2012). In contrast, several studies have also found that longer 
duration of US residence to be beneficial, including increased earnings, better English 
proficiency, access to healthcare and knowledge on US healthcare system (Chesney et al. 
1982; Kaushal and Kaestner 2013; Marks, Garcia, and Solis 1990; O’Malley et al. 1999; 
Pérez-Stable, Marín, and Marín 1994; Wong, Díaz, and Higgins 2006). Because health 
 
80 
 
behaviors and using healthcare services are directly associated with the development and 
detection of diabetes, it is expected that a large share of variation between foreign-born 
individuals in terms of diabetes and undiagnosed diabetes could be captured when 
duration of residence is accounted for.  
Given a positive association between length of residence and several health 
indicators that are key risk factors for diabetes, such as BMI (Gregg et al., 2004), 
smoking (Willi, Bodenmann, Ghali, Faris, & Cornuz, 2007) and psychosocial stress 
(Kelly & Ismail, 2015), it is logical to assume that immigrants with longer US duration 
have a higher risk of diabetes than recent arrivals. Although findings vary depending on 
study designs, prior studies in general reported a positive relationship between longer 
duration of US residence and the prevalence of diabetes. Riosmena, Wong and Palloni 
(2013) found that Mexican immigrants with 15+ years of duration of residence in the US 
had a significantly higher risk of reporting self-reported diabetes than those with <5 years 
of duration. However, there were no significant differences between 5-9 years and 10-14 
years, and <5 years of duration of stay. Horlyck-Romanovsky et al. (2019) reported a 
significant difference in the odds of self-reported diabetes between foreign-born blacks 
with less than 10 years of US residence and those with 10 years or longer stay. Another 
national study using NHIS waves of 1997-2005 found an increase in adjusted prevalence 
of diabetes with increased length of residence in the United States, independent of BMI 
(Oza-Frank, Stephenson and Narayan, 2011). One study that measured diabetes based on 
fasting glucose level and the use of diabetes medication found that immigrants living in 
the US for 20 years or longer had a higher adjusted risk of incident diabetes than those 
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with less than 20 years of duration of stay, but this study is limited to a small sample size 
and focuses on incident diabetes only (Oza-Frank et al., 2013).  
Most of these studies focused on self-reported diabetes. As discussed earlier, 
using self-reported diabetes is subject to a underreporting problem, which leads to an 
underestimation of the actual prevalence of diabetes among immigrants. Using a variety 
of measures of diabetes, such as self-reported diabetes, biomarkers of diabetes and 
undiagnosed diabetes, can help to elucidate how duration of stay may be correlated with 
diabetes. First, immigrants with a longer duration of stay may have an increase in the risk 
of diabetes if they adopt unfavorable US health behaviors, i.e., cigarette smoking and 
unhealthy diet, over time. This process results in an increase in the prevalence of both 
self-reported diabetes and diabetes identified by biomarkers. Second, as immigrants have 
improved healthcare access and better health insurance with increasing duration of 
residence, the immigrants can have a better chance of finding out their diabetes status, 
resulting in an increase in detected cases and thus an increase in the prevalence of self-
reported diabetes, regardless of changes in the actual incidence of the disease in this 
population (Antecol & Bedard 2006; McDonald and Kennedy 2004). Lastly, given that a 
longer duration of stay is associated with access to preventive healthcare and timely 
screening of diabetes, the prevalence of diabetes may not be associated with longer 
duration of US residence.  
It is likely that all three pathways operate at the same time offsetting each other, 
attenuating the reliability of the association between duration of stay and diabetes. One 
way to avoid this problem is to further estimate the association between time in the US 
and biomarkers for diabetes and undiagnosed diabetes. If the second scenario is true, the 
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prevalence of diabetes identified by biomarkers would remain constant over time, while 
the prevalence of self-reported diabetes among the foreign-born would increase with the 
decrease in undiagnosed diabetes.  
3.3 Aims of Chapter 3 
The aims of this chapter are twofold. The first aim is to examine the relative 
diabetes risk of US immigrants compared with native-born Americans by focusing on 
self-reported diabetes, a biomarker for diabetes and undiagnosed diabetes. The second 
goal is to assess the association between the three diabetes outcomes among immigrants 
by the duration of US residence.     
3.4 Data and Methods 
3.4.1 Data and Sample 
Data are from the National Health and Nutrition Examination Survey (NHANES) 
3 (1988-1994) and 1999-2016 waves of continuous NHANES. The NHANES is a series 
of cross-sectional household surveys that collect information from a nationally 
representative sample of the non-institutionalized civilians in the United States. All 
analyses in this chapter were based on public-use data. The sample of this study was 
restricted to self-identified native-born and foreign-born non-Hispanic whites, non-
Hispanic blacks and Hispanics aged 30-80. Of all NHANES participants who meet the 
above criteria (n=47,944), those with missing information on diabetes status and 
explanatory variables were excluded from the analyses (n=5,589 or 11.7%), yielding a 
final sample size of 42,355 adults. Most of the missing cases are from data on HbA1c 
(n=4,743), resulting from the fact that some NHANES participants did not attend 
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subsequent NHANES examination sessions after they were surveyed. Other missing 
cases are from BMI, smoking behavior and education (n=846).     
3.4.2 Variable Definitions 
The main dependent variables are: (1) self-reported diagnosed diabetes; (2) 
HbA1c measurement of at least 6.5% and (3) undiagnosed diabetes. Self-reported 
diabetes is constructed based on the survey question “Other than during pregnancy, have 
you ever been told by a doctor or health professional that you have diabetes or sugar 
diabetes?” If answered “yes” to this question, then the respondents are assigned as 
diabetic. Participants who answered “no” or “borderline” are considered as non-diabetic. 
Participants with HbA1c ≥ 6.5% are categorized as diabetic based on the American 
Diabetes Association criteria (ADA, 2010). In addition, among participants with HbA1c 
<6.5%, those who were using insulin or taking diabetes pills are also considered as 
diabetic, following previous literature (Stokes & Preston, 2017). Throughout the chapter, 
I refer two diabetic groups, participants with HbA1c ≥ 6.5%, and HbA1c < 6.5% and 
taking diabetes medication, as “HbA1c ≥ 6.5%.” Undiagnosed diabetes is defined as 
having HbA1c ≥ 6.5% without self-reported diabetes. 
Other covariates include age, nativity, race/ethnicity, sex, education, cigarette 
smoking, BMI and survey years. Age is used as continuous. Race/ethnicity is constructed 
based on self-reported ethnicity and categorized as non-Hispanic white (Whites 
hereafter), non-Hispanic black (Blacks hereafter) and Hispanic. Nativity is categorized as 
US-born or foreign-born: participants who reported being born in one of 50 US States or 
Washington DC are coded as US-born, while those who reported being born in Mexico, 
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another Spanish speaking country, or other foreign country are considered to be foreign-
born. For the foreign-born, the survey further asked years spent in the U.S. and nine 
categories of length of residence are provided in publicly available NHANES. In 
preliminary analyses, I observed that there is little variation or inconsistency between the 
categories less than 15 years in terms of the prevalence of self-reported diabetes and 
HbA1c ≥6.5%, and mean HbA1c level (Table A2). Also, estimates for the short-duration 
categories showed high level of uncertainty due to a small sample size. Therefore, I 
collapsed the nine categories into two groups to obtain reliable estimates with statistical 
power: (1) less than 15 years and (2) 15 years or longer US residence. Education was 
coded into four categories: (1) less than high school; (2) high school diploma or general 
educational diploma; (3) some college; and (4) four years of college or more. Smoking 
behavior was coded as current, former, or never smoker based on two survey questions: 
“Have you smoked at least 100 cigarettes in your entire life?” and “Do you now smoke 
cigarettes?” I created a dichotomous variable for not having access to healthcare; 
participants were coded as 1 if they reported they don’t have a place when they are sick 
or need advice about health and 0 otherwise.  
Baseline BMI (kg/m2) was measured as a continuous variable as well as 
categorized into four classifications: under or normal weight (< 25.0 kg/m2), overweight 
(25.0-29.9 kg/m2), obese class I (30.0-34.9 kg/m2) and obese class II/III (≥35.0 kg/m2). In 
regression models, BMI was used as a continuous variable above BMI equal to 18.5 
kg/m2 and values above 18.5 kg/m2 were coded as BMI value – 18.5 kg/m2. BMI values 
below 18.5 kg/m2 were coded as 0. Also, a BMI squared term is used to reflect a possible 
non-linear relationship between diabetes and BMI. In a preliminary analysis. Models with 
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BMI and BMI squared showed better model fits than models with BMI as a categorical 
variable.  
3.4.3 Statistical Approach 
After presenting descriptive information on the sample by nativity, age-
standardized rates of three diabetes outcomes are presented for all covariates using the 
2010 US-population age distribution by 5-year age intervals as the standard. To predict 
nativity differentials in diabetes net of confounding factors, I estimate five multivariate 
logistic regression models for the three outcomes. For undiagnosed diabetes, the analytic 
sample is restricted to those with HbA1c levels greater than or equal to 6.5% among 
those with undiagnosed diabetes and the model thus estimates the probability that 
diabetes remains undetected. Model 1 includes nativity status, age, sex and survey year. 
Model 2 further controls for education. Model 3 additionally adjusts for race/ethnicity. 
Model 4 adds smoking behavior and having a place for healthcare. Model 5 further 
controls for BMI and BMI squared. In Model 5, only BMI variables are additionally 
introduced because I found a prominent role of BMI in explaining the nativity gap in 
diabetes.  
The effect of duration of US residence is tested in Model 6 and 7. In these models, 
the foreign-born are divided into two groups by reported length of residence, less than 15 
years and 15 years or longer duration of stay. These foreign-born groups are compared to 
the native-born in both Models 6 and 7. Model 6 adjusts for the covariates used in Model 
4, while Model 7 controls for the variables introduced in Model 5. After fitting these 
models, predicted probability of the three diabetes outcomes are calculated based on 
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coefficients from Model 7, which is a full model with all covariates, and results are 
graphically presented in Figure 3-1.   
Potential heterogeneity in associations by race/ethnicity is tested by including 
interaction terms between race/ethnicity and nativity. The results from this analysis are 
not shown as the interaction effects are found to be insignificant. To further investigate 
the role of race/ethnicity in combination with nativity, an additional analysis is conducted 
in which age-standardized prevalence of three diabetes outcomes and major covariates 
are calculated by race/ethnicity and nativity (Table A3).  
3.4.4 Sensitivity Analysis 
Previous research of diabetes shows variation in their findings depending on the 
definition of diabetes. To assess the effect of different definitions of diabetes on the 
results of this chapter, I use three additional definitions of diabetes and estimate logistic 
models with the new diabetes criteria. These definitions are (1) fasting plasma glucose ≥ 
126mg/dL only, (2) fasting plasma glucose ≥ 126mg/dL or HbA1c ≥ 6.5% (3) fasting 
plasma glucose ≥ 126mg/dL, HbA1c ≥ 6.5% or self-reported diabetes. Undiagnosed 
diabetes is also newly defined based on both FPG and HbA1c: having either HbA1c ≥ 
6.5% or fasting plasma glucose ≥ 126mg/dL, but did not report self-reported diabetes. 
Because only NHANES respondents who attended morning fasting session had 
information on plasma glucose level, the analyses are restricted to these respondents 
(n=25,959).  
3.5 Results 
3.5.1 Descriptive Analysis 
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Table 3-1 summarizes the descriptive information of the sample by nativity. Of 
the 42,355 NHANES participants aged 30-80, 87.6% were US-born and 12.4% were 
foreign-born individuals. Among the foreign-born, 36.7% and 64.7% lived in the US for 
less than 15 years and 15 years or longer, respectively. The prevalence of self-reported 
diabetes was higher for the foreign-born (10.1%) than the US-born (9.6%). When 
diabetes was measured by HbA1c ≥ 6.5%, the same pattern was revealed: 12.2% of the 
foreign-born and 11.0% of the US-born had diabetes. The prevalence of undiagnosed 
diabetes among participants whose HbA1c levels were equal to or greater than 6.5% was 
also higher for foreign-born individuals (28.6%) than the US-born (21.9%). The US-born 
(52.0 years) were older than the foreign-born (47.9 years). Whites constituted the 
majority of the US-born group (84.0%), while Hispanics (62.6%) accounted for the 
largest share of the foreign-born, followed by Blacks (28.0%). The US-born had a in 
general higher educational attainment than the foreign-born: nearly 40% of the foreign-
born individuals had less than high school education, but only a quarter of the US-born 
had the same educational attainment. US-born individuals showed a slightly higher mean 
BMI (29.1 kg/m2) than the foreign-born (28.5 kg/m2). Looking at BMI classifications, the 
US-born were less likely to be overweight (22.3% vs 41.1%) and obese classⅠ(20.8% vs 
22.7%) than the foreign-born. However, the native-born were more likely to be obese 
classⅡ/Ⅲ (16.2% vs 10.6%) and also be under or normal weight (28.6% vs 25.6%) than 
the foreign-born. While most US-born adults reported that they have access to healthcare 
services when they have a health problem (89.7%), a smaller proportion of the foreign-
born reported such accessibility (76.1%). Among the foreign-born, 63.3% reported that 
they had lived in the US for 15 years or longer.  
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Table 3-2 presents age-standardized prevalence of diabetes outcomes by all 
covariates. For undiagnosed diabetes, the prevalence among those with HbA1c ≥ 6.5% 
and among the entire sample is separately presented. For all three outcomes, age-adjusted 
prevalence among the foreign-born exceeded that of the US-born; self-reported diabetes 
(11.4% vs 8.8%), HbA1c ≥ 6.5% (13.6% vs 10.1%) and undiagnosed diabetes (40.0% vs 
26.7% among those with HbA1c ≥ 6.5% and who reported that they had not been 
diagnosed with diabetes, and 3.7% vs 2.2% among the entire sample). Among foreign-
born adults, those with longer duration of US residence had a higher prevalence of the 
three diabetes outcomes than foreign-born adults with shorter duration of stay. Compared 
with women, men had a slightly higher prevalence of self-reported diabetes (9.7% vs 
8.5%), HbA1c ≥ 6.5% (11.5% vs 9.5%) and undiagnosed diabetes (29.7% vs 27.9%). 
There were considerable racial/ethnic disparities in the prevalence of the diabetes 
outcomes; Blacks and Hispanics were disadvantaged in self-reported diabetes (15.3% for 
Blacks, 14.7% for Hispanics and 7.6% for Whites), HbA1c ≥ 6.5% (18.3% for Blacks, 
17.2% for Hispanics and 8.6% for Whites) and undiagnosed diabetes (31.8% for Blacks, 
32.1% for Hispanics and 26.0% for Whites) when compared with Whites. There was also 
a clear educational gradient in the three outcomes with the less educated showing a 
higher prevalence than the more educated. As expected, the age-adjusted prevalence of 
self-reported diabetes, HbA1c ≥ 6.5% and undiagnosed diabetes increased sharply with 
BMI. Participants with obese class II/III (BMI ≥ 35.0 kg/m2) had a particularly high 
prevalence compared to any other BMI group. Among participants with obese class I (30-
34.9 kg/m2), for instance, the prevalence of self-reports, HbA1c ≥ 6.5% and undiagnosed 
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diabetes was 11.8%, 14.3% and 3.5%, respectively, but the prevalence was very high at 
19.6%, 24.2% and 6.2% in obese class II/III.  
3.5.2 Results from Logistic Regression Models 
Tables from 3-3 through 3-5 present logistic regression analyses for self-reported 
diabetes (Table 3-3), HbA1c ≥ 6.5% (Table 3-4) and undiagnosed diabetes (Table 3-5). 
All coefficients are expressed as a form of odds ratios (ORs). Analyses for undiagnosed 
diabetes were performed among the participants with HbA1c ≥ 6.5% and individuals who 
reported that they had not been diagnosed with diabetes. Model 1, which adjusts for 
nativity, age and sex, shows that foreign-born individuals had 28% higher odds of 
reporting self-reported diabetes (OR: 1.28, 95% CI: 1.13-1.45) relative to US-born 
individuals. Similarly, foreign-born adults had 36% higher odds of having HbA1c ≥ 6.5% 
(OR:1.36, 95% CI:1.22-1.51) compared to the US-born. The foreign-born were also more 
likely to underreport their diabetes (OR: 1.40, 95% CI: 1.11-1.76) than the US-born. 
Model 1 also shows that adjusted risk of diabetes among the sample has increased over 
the period studied, while a decrease in the risk of undiagnosed diabetes was observed.  
Model 2 additionally adjusts for educational attainment. In this model, nativity 
differences in self-reported diabetes (OR: 1.08, 95% CI: 0.95-1.23) and HbA1c ≥ 6.5% 
(OR: 1.15, 95% CI: 1.03-1.28) are reduced to some extent compared with Model 1. 
However, odds ratio for undiagnosed diabetes increased from 1.40 (95% CI: 1.40-1.76 in 
Model 1) to 1.46 (95% CI: 1.14-1.88 in Model 2). As expected, there was a strong 
relationship of self-report of diabetes and HbA1c ≥ 6.5% with education. However, there 
was no significant educational gradient with regard to undiagnosed diabetes. 
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When race and ethnicity is introduced in Model 3, the foreign-born became 
significantly less likely to have diabetes than the US-born and this change was observed 
for both self-reported diabetes (OR:0.75, 95% CI:0.64-0.88) and HbA1c ≥ 6.5% 
(OR:0.79, 95% CI:0.69-0.91). In addition, there was a strong association between 
race/ethnicity and the excess prevalence of diabetes: when compared to Whites, Blacks 
and Hispanics were more than twice as likely to have self-reported diabetes and HbA1c ≥ 
6.5% than Whites. For undiagnosed diabetes, the inclusion of race/ethnicity did not alter 
the pattern observed in Model 1 and 2; foreign-born individuals were more likely to have 
unknown diabetes than US-born Americans (OR:1.48, 95% CI:1.13-1.94). In addition, 
the risk of undiagnosed diabetes did not significantly vary by race/ethnicity. 
Model 4 further adds smoking behaviors and access to healthcare. Adjusting for 
these variables slightly increases odds ratios of being-foreign born for self-reported 
diabetes (OR:0.80, 95% CI:0.69-0.94) and HbA1c ≥ 6.5% (OR:0.83, 95% CI:0.73-0.95), 
reducing gaps in the nativity difference in diabetes. Compared with never smokers, 
former smokers had higher odds, while current smokers had lower odds of self-reported 
diabetes and HbA1c ≥ 6.5%. Having access to healthcare was positively and strongly 
associated with self-reported diabetes (OR: 3.51, 95% CI: 2.75-4.48) and HbA1c ≥ 6.5% 
(OR: 2.35, 95% CI: 1.93-2.87). In contrast, there was a negative and significant 
association between undiagnosed diabetes and having access to healthcare (OR: 0.33, 
95% CI: 0.24-0.46). 
The final model additionally controls for BMI and BMI squared. In this model, 
the BMI variables retained their strong association with all three outcomes. In addition, 
the inclusion of BMI diminished the foreign-born advantage with self-reported diabetes 
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(OR: 0.97, 95% CI: 0.83-1.13) and HbA1c ≥ 6.5% (OR: 1.05, 95% CI: 0.91-1.21), 
making the associations statistically insignificant. For undiagnosed diabetes, the odds 
ratio of being foreign-born was almost intact (OR: 1.53, 95% CI: 1.16-1.21). As 
expected, BMI was positively associated with having self-reported diabetes, HbA1c ≥ 
6.5%, and undiagnosed diabetes. Furthermore, controlling for the BMI variables 
considerably reduced higher odds ratios for recent years compared with years 1988-1994, 
indicating that increasing BMI in the US population has contributed to an increase in 
prevalence of diabetes in recent years.  
The association between the length of US residence and the diabetes outcomes is 
tested in Model 6 and 7 (Table 3-6). In these models, the foreign-born sample was 
divided by the duration of residence (< 15 years vs. 15+ years). In Model 6, the foreign-
born with <15 years of residence had lower risks of self-reported diabetes (OR:0.59, 95% 
CI: 0.48 – 0.74) and HbA1c ≥ 6.5% (OR:0.68, 95% CI: 0.56 – 0.83) when compared to 
the US-born. However, foreign-born adults with 15 + years of residence did not have 
such advantage in either self-reported diabetes (OR:0.88, 95% CI: 0.74 - 1.04) and 
HbA1c ≥ 6.5% (OR:0.89, 95% CI: 0.77 - 1.03). In addition, both foreign-born groups by 
duration of stay were significantly more likely to have undiagnosed diabetes than their 
US-born counterparts. In Model 7 in which BMI and BMI squared are further introduced, 
the lower risk of diabetes for foreign-born adults with < 15 years of residence observed in 
Model 6 only remained significant for self-reported diabetes (OR:0.78, 95% CI: 0.62-
0.98), but not for HbA1c ≥ 6.5% (OR:0.96, 95% CI: 0.77-1.18). In addition, the foreign-
born with 15+ years of residence were not significantly different from the US-born in 
either self-reported diabetes (OR:0.89, 95% CI: 0.77-1.03) or HbA1c ≥ 6.5% (OR:1.08, 
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95% CI: 0.93-1.26). With regard to undiagnosed diabetes, both foreign-born groups had 
significantly higher odds than their US-born counterparts. Furthermore, the magnitude of 
the odds ratios of undiagnosed diabetes were found to be greater for those with <15 years 
of residence than those with 15+ years of residence by 25-30%.  
Figure 3-1 summarizes predicted probabilities of the three outcomes based on 
coefficients of Model 7 in Table 3-6. When diabetes was measured based on self-
reported, the foreign-born with <15 years of residence appeared to have a significantly 
lower probability of having diabetes compared with the US-born as well as the foreign-
born with 15+ years of residence. However, the foreign-born with 15 + years of residence 
were not significantly different from the native-born. Despite this significant effect of the 
duration of residence with regard to self-reported diabetes, there were no significant 
difference between the US-born, the foreign-born with <15 years and 15+ years of 
residence when diabetes was diagnosed based on the HbA1c criterion. For undiagnosed 
diabetes, both foreign-born groups had a significantly higher probability than the US-
born. Although two foreign-born groups did not significantly differ in terms of the 
probability of undiagnosed diabetes, the probability was lower for the long-term foreign-
born group than recent arrivals.  
3.5.3 Results from the Sensitivity Analysis 
Table 3-7 presents results from sensitivity analyses. These analyses test three 
different definitions of diabetes using FPG: (1) FPG ≥ 126 mg/dL; (2) HbA1c ≥ 6.5% or 
FPG ≥ 126 mg/dL; and (3) HbA1c ≥ 6.5%, FPG ≥ 126 mg/dL or self-reported diabetes. 
Model 8 and Model 9 (Table 3-7) adjust for covariates used in Model 4 and Model 5 
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(Table 3-3), respectively. These models with new definitions of diabetes show very 
similar diabetes and nativity patterns observed in the previous models of self-reported 
diabetes and HbA1c ≥ 6.5%. These observations suggest that the results from this chapter 
are not affected by how diabetes is identified.    
 
3.6 Discussion 
Previous studies of diabetes have reported inconsistent or conflicting findings on 
whether immigrants have a favorable diabetes status compared to their US-born 
counterparts. One of the limitations in the literature is that most previous studies 
identified diabetes based solely on self-reported diabetes. However, using self-reported 
diabetes could provide inaccurate estimates of the actual risk of diabetes among the 
foreign-born due to their limited healthcare use. Therefore, I reexamined this issue by 
focusing on both self-reported diabetes, a HbA1c measurement and undiagnosed 
diabetes. To the best of my knowledge, these are the first estimates of diabetes among 
foreign-born vs. US-born individuals based on the three diabetes outcomes.  
I found that the age-standardized prevalence of diabetes was higher among the 
foreign-born than the US-born (Table 3-2). The higher risk of diabetes among the 
foreign-born was also observed in logistic regression models in which age, sex, and 
education were adjusted for (Model 1 in Table 3-3 and Table 3-4). However, controlling 
for race/ethnicity reversed this pattern such that the foreign-born now had a significantly 
lower risk of diabetes than the US-born (Model 3 in Table 3-3 and Table 3-4). With 
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additional inclusion of BMI in the model, the significant difference in diabetes between 
the foreign-born and the US-born disappeared (Model 5 in Table 3-3 and Table 3-4).  
One of the main goals of this chapter is to assess a possible misclassification bias 
from using self-reported diabetes. Results from logistic models for self-reported diabetes 
(Table 3-3) and HbA1c ≥ 6.5% (Table 3-4) show that there was little difference in the 
estimated odds ratios for these two measures. Furthermore, age-standardized prevalence 
presented in Table 3-2 exhibits very similar values for self-reported diabetes and HbA1c 
≥ 6.5%. These results suggest that estimates based on self-reported diabetes well reflect 
the actual difference in the prevalence and relative risk of diabetes between the foreign-
born and the US-born as a whole.  
On the other hand, the results also show that the foreign-born had 53 percent 
higher odds of having undiagnosed diabetes compared to the US-born (Model 5 in Table 
3-5). This result implies the existence of a misclassification bias that is more serious for 
the foreign-born relative to the US-born when diabetes is diagnosed based on self-reports. 
Yet, as seen previously, the problem of underreporting diabetes does not stand out when 
comparing results from logistic regression models for self-reported diabetes (Table 3-3) 
and HbA1c ≥ 6.5% (Table 3-4). This is because the prevalence of undiagnosed diabetes 
in the entire sample was very low at 2.2% among the US-born and 3.7% among the 
foreign-born. That is, cases of undiagnosed diabetes were too small to make a notable 
impact of undiagnosed diabetes when the entire sample is analyzed, although the relative 
risk of unknown diabetes was much greater for the foreign-born than the US-born based 
on HbA1c ≥ 6.5%.   
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The impact of higher prevalence of undiagnosed diabetes among the foreign-born 
becomes discernable with a consideration of duration of residence, which is graphically 
described in Figure 3-1. Using self-reported diabetes, diabetes prevalence was positively 
associated with longer residence in the US, supporting the acculturation hypotheses. 
When diabetes is diagnosed based on HbA1c levels, however, there was no significant 
differences among the US-born and the two foreign-born groups defined by duration of 
residence. There was, however, significant difference between the US-born and the 
foreign-born in undiagnosed diabetes with the difference being less pronounced for those 
with longer duration in the United States. Altogether, findings from Figure 3-1 suggest 
that the observed lower risk of self-reported diabetes for the foreign-born immigrants 
with <15 years of US residence over the US-born and those with longer stay in the US 
was a product of a higher probability of underreported diabetes among the immigrants 
with shorter duration of residence. This finding suggests that foreign-born individuals 
with longer duration of residence are more likely to have found out that they have 
diabetes, perhaps because of their access to health care has improved over time 
(McDonald and Kennedy 2004; Leclere, Jesen and Biddlecom, 1994). When diabetes is 
measured by HbA1c criterion, there is no difference in diabetes prevalence among the 
foreign-born by length of US stay. Thus, in contrast to other studies that used self-
reported diabetes, there is no evidence here that duration of US stay results in an 
increased risk of diabetes (Oza-Frank, Stephenson and Narayan, 2011; Oza-Frank et al., 
2013; Horlyck-Romanovsky et al.,2019). 
Furthermore, I found that race/ethnicity plays an important role in understanding 
nativity differentials in diabetes. Results from logistic regression models show that when 
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controlling for race/ethnicity the foreign-born are at a lower risk of self-reported diabetes 
and HbA1c ≥ 6.5% compared with the native-born. This table shows that within each 
racial/ethnic group foreign-born individuals had lower age-standardized prevalence of 
diabetes than the US-born. Thus, when controlling for both nativity and race/ethnicity the 
foreign-born have lower risk of diabetes than the US-born (Model 3, Table 3-3). Without 
controls for race/ethnicity in Model 1, Table 3-3, the foreign-born have a higher risk of 
diabetes than the native-born due to the fact that Whites make up 84% of the US born, 
and they have a lower prevalence of diabetes (8.6%) than foreign-born Blacks (10.9%) 
and Hispanics (11.5%), who make up 90.6% of the foreign-born.  
This higher age-adjusted risk of diabetes among racial minorities, regardless of 
their nativity status, is consistent with previous literature that demonstrates higher 
morbidity rates among ethnic minority populations when compared to Whites (Herbeck 
et al., 2013). Hispanics and Blacks in the US have been found to be disproportionately 
affected by hypertension, asthma, arthritis, and chronic medical conditions than Whites 
due to racial minorities’ lower SES, barriers to healthcare services, disadvantaged early-
life experiences (Aday 2001; Benjamin-Johonson et al, 2009; Cunninghmal et al, 2006; 
Mertens et al., 2008; Braveman and Barclay, 2009).     
I also found a profound impact of BMI on nativity differentials in diabetes, which 
has also been reported in other studies (Ford et al., 2016; Kumar, Wong, Ottenbacher and 
Snih, 2016). The distribution of BMI classifications by nativity (Table 3-1) and 
corresponding age-standardized prevalence of diabetes (Table 3-2) suggests a possible 
role of BMI. The weighted proportion of overweight (25.0-29.9 kg/m2) and obese 
classⅠ(30.0-34.9 kg/m2) were lower among the US-born as compared to the foreign-
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born, but the proportion of obese class Ⅱ/Ⅲ (≥ 35.0 kg/m2) was higher among the US-
born (16.2%) than among the foreign-born (10.6%). In addition, high age-standardized 
prevalence of diabetes was marked for obese class Ⅱ/Ⅲ (19.6% and 24.2% based on 
self-report and HbA1c ≥ 6.5%, respectively). Given these distributions, it is likely that 
the US-born adults with extremely high BMI contributed to the excess prevalence of 
diabetes among the US-born. The important role of BMI in this chapter partly supports 
the cultural buffering hypothesis: healthier lifestyles and diet of foreign-born individuals 
are associated with their favorable health outcomes (Singh and Siahpush, 2002).  
In addition, this chapter found weak support for the positive selection of migrants 
in terms of diabetes. As shown in Table 3-2, foreign-born individuals as a group had a 
higher age-standardized prevalence of all three diabetes outcomes than the native-born 
individuals. When stratified by race/ethnicity, however, within each racial/ethnic group 
the foreign-born had lower age-standardized prevalence of diabetes (Table A3 in 
Appendix). This finding is consistent with prior evidence and the healthy migrant 
hypotheses within race/ethnicity (Mehta & Elo, 2012; Cunningham et al., 2008). This 
heath advantage is in part due to the lower prevalence of extreme BMI among the 
foreign-born compared to the US-born.  
In summary, this chapter has three main findings that provide important insights. 
First, race/ethnicity and BMI play a critical role in understanding nativity disparities in 
the risk of diabetes. Racial and ethnic minorities tended to have a higher prevalence of 
diabetes than Whites and, at the same time, foreign-born individuals within the same 
racial/ethnic group were found to have a lower prevalence than their US-born 
counterparts. In addition, the overall sample mean of BMI masks high rates of people 
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with extremely high BMI among US-born Americans. This high prevalence of obesity 
among the US-born contributes to their higher prevalence of diabetes. Second, using self-
reported diabetes and a measurement of HbA1c provides very similar estimates of the 
prevalence of diabetes for both the US-born and the foreign-born. Third, this study also 
confirms a misclassification bias when using self-reported diabetes among the foreign-
born, which was greater for the foreign-born with shorter duration of stay in the United 
States. However, the degree to which the bias affects the comparison of the risks of 
diabetes between the US-born and the foreign-born in the sample was small because the 
prevalence of undiagnosed diabetes in the entire sample was very small (2.4% among the 
US-born and 3.5% among the foreign-born). 
Several limitations of this chapter should be acknowledged. First, the cross-
sectional data within the US does not account for return migrants whose diabetes status 
may differ from those remaining in the United States. Second, the length of US stay, i.e., 
the duration effect may vary by SES and other demographic characteristics of the 
foreign-born (Li and Hummer, 2014; Cho et al., 2004). This possibility was not examined 
because the sample size of the foreign-born is too small to categorize this group by 
duration as well as other characteristics. Prior literature also suggests that duration of stay 
in the United States may not accurately reflect the migrant’s exposure to the US 
environment (Massey and Capoferro, 2004). In addition, each of the racial/ethnic groups 
is made up of heterogeneous subpopulations in terms of their place of birth (Horlyck-
Romanovsky et al., 2019; Mehta & Elo, 2012; Elo et al., 2011; Oza-Frank & Narayan, 
2010). Although foreign-born subpopulations from different origins are expected to have 
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a different risk of diabetes, this chapter cannot examine this possibility due to data 
limitations.  
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TABLES 
Table 3-1. Characteristics of the NHANES Sample by Nativity. Ages 30-80. 
 US-born 
(N= 33,839) 
Foreign-born 
(N= 8,516)  
Weighted % 87.6 12.4 
Diabetes    
  Self-reported diabetes 9.6 10.1 
  HbA1c ≥ 6.5% 11.0  12.2 
  Undiagnosed diabetesa 2.4 (21.9) b 3.5 (28.6) b 
Male 47.5 50.2 
Age at baseline, in years (SD) 52.0 (14.4) 47.9 (11.5) 
Race/ethnicity   
  Non-Hispanic white 84.0 28.0 
  Non-Hispanic black 11.2 9.4 
  Hispanic 4.8 62.6 
Educational attainment   
  Less than high school  15.0 41.2 
  High school graduate 25.8 17.1 
  Some college 30.0 20.9 
  4 years college + 29.2 20.8 
Smoking behavior   
  Never smoker 48.6 61.7 
  Current smoker 22.3 15.7 
  Former smoker 29.2 22.6 
BMI (kg/m2), mean (SD) 29.1(5.5) 28.5(5.9) 
BMI classifications   
  Underweight or Normal (-24.9 kg/m2) 28.6 25.6 
  Overweight (25.0-29.9 kg/m2) 34.3 41.1 
  Obese class Ⅰ (30.0-34.9 kg/m2) 20.8 22.7 
  Obese class Ⅱ/Ⅲ (≥ 35.0 kg/m2) 16.2 10.6 
Access to health care (yes) 89.7 76.1 
Survey years   
  1984-1994 8.5 3.3 
  1999-2004 28.3 28.8 
  2005-2010 30.5 32.2 
  2011-2016 32.6 35.7 
Duration of residence, in years   
  Less than 15 years  - 36.7 
  15 + years - 63.3 
Percentages were calculated using NHANES survey weights. 
Source: NHANES Ⅲ (1988-1994) and continuous NHANES 1999-2016. 
aUndiagnosed diabetes is defined as HbA1c ≥ 6.5% without self-reported diagnosed diabetes. 
bWeighted prevalence of undiagnosed diabetes among participants with HbA1c ≥ 6.5%
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Table 3-2. Age-standardized Prevalence of Diabetes Outcomes by Covariates. Ages 30-80. 
 Self-reported diabetes HbA1c ≥ 6.5% Undiagnosed diabetesa Undiagnosed diabetesb 
 % 95% CI % 95% CI % 95% CI % 95% CI 
Nativity         
   US-born 8.8 8.4-9.2 10.1 9.7-10.6 26.7 23.7-29.8 2.2 2.1-2.4 
   Foreign-born 11.4 10.3-12.5 13.6 12.5-14.8 40.0 35.2-45.0 3.7 3.2-4.3 
Duration of residencec         
   Less than 15 years  9.5 7.9-11.3 12.5 10.8-14.4 41.9 34.9-49.4 4.0 3.0-5.3 
   15 + years 12.1 10.9-13.4 14.0 12.8-15.3 36.1 28.6-44.4 3.6 3.1-4.3 
Sex         
   Male 9.7 9.2-10.3 11.5 10.9-12.2 29.7 26.4-33.1 2.7 2.4-3.1 
   Females 8.5 8.0-9.0 9.5 9.0-10.1 27.9 24.3-31.8 2.1 1.9-2.4 
Race/ethnicity         
   Non-Hispanic white 7.6 7.2-8.1 8.6 8.1-9.1 26.0 21.9-30.5 1.9 1.7-2.1 
   Non-Hispanic black 15.3 14.6-16.1 18.3 17.4-19.1 31.8 27.8-36.2 4.3 3.8-4.8 
   Hispanic 14.7 13.6-15.8 17.2 16.0-18.4 32.1 28.3-36.3 4.3 3.9-4.8 
Educational attainment         
   Less than high school  13.0 12.3-13.7 15.2 14.5-16 31.6 27.3-36.3 3.5 3.1-4.0 
   High school graduate 9.1 8.4-9.9 10.5 9.8-11.3 28.1 23.1-33.8 2.5 2.1-2.9 
   Some college 9.5 8.8-10.2 10.9 10.1-11.6 27.1 22.8-31.9 2.5 2.1-2.9 
   4 years college + 5.9 5.4-6.6 6.7 6.1-7.3 30.7 23.4-39.1 1.6 1.3-1.9 
Smoking behavior         
   Never smoker 8.9 8.4-9.5 10.3 9.7-10.9 28.3 25.0-31.9 2.3 2.0-2.6 
   Current smoker 8.5 7.7-9.3 9.9 9.1-10.6 29.6 25.1-34.5 2.4 2-2.9.0 
   Former smoker 9.5 8.9-10.1 11.1 10.4-11.9 30.8 25.2-37.1 2.7 2.3-3.1 
BMI classifications (kg/m2)         
   Normal weight (-24.9) 3.9 3.4-4.4 3.7 3.3-4.2 14.8 10.2-20.8 0.6 0.4-0.8 
   Overweight (25.0-29.9) 6.8 6.3-7.3 7.3 6.8-7.8 24.6 20.0-29.9 1.5 1.3-1.7 
   Obese class Ⅰ (30.0–34.9) 11.8 10.9-12.7 14.3 13.4-15.3 30.2 25.9-34.8 3.5 3.1-4.0 
   Obese class Ⅱ/Ⅲ (≥ 35.0) 19.6 18.3-21.1 24.2 22.8-25.6 32.5 28.4-36.9 6.2 5.4-7.0 
Having healthcare         
   Yes 9.6 9.2-10.1 10.9 10.4-11.4 26.5 23.8-29.4 2.4 2.2-2.6 
   No 3.4 2.7-4.4 5.7 4.7-6.8 51.2 43.7-58.7 2.6 2.1-3.3 
Survey years         
   1984-1994 6.4 5.7-7.1 7.8 7-8.7.0 41.1 33.7-48.9 2.6 2.2-3.0 
   1999-2004 8.2 7.5-8.9 8.9 8.2-9.7 27.4 21.8-33.8 1.8 1.6-2.1 
   2005-2010 9.0 8.2-9.9 10.7 9.9-11.6 29.4 26.0-33.0 2.7 2.3-3.0 
   2011-2016 10.7 10.0-11.5 12.3 11.4-13.3 27.5 23.3-32.1 2.7 2.3-3.1 
aAmong participants with HbA1c ≥ 6.5%. bAmong the entire sample. cAmong the foreign-born. 
2010 US population for both men and women was used as the standard population.
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Table 3-3. Odds Ratios from Multivariate Logistic Regressions for Self-Reported Diabetes. Ages 30-80 (n=42,355). 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Nativity            
US-born (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
Foreign-born 1.28 1.13-1.45 1.08 0.95-1.23 0.75 0.64-0.88 0.80 0.69-0.94 0.97 0.83-1.13 
Age, in years 1.05 1.05-1.05 1.05 1.04-1.05 1.05 1.05-1.05 1.04 1.04-1.05 1.05 1.05-1.06 
Male  1.19 1.09-1.30 1.22 1.12-1.33 1.24 1.14-1.35 1.29 1.18-1.42 1.40 1.28-1.53 
Educational attainment           
    < High school (ref)   1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
    High school graduate   0.68 0.61-0.76 0.77 0.69-0.86 0.74 0.66-0.83 0.74 0.66-0.83 
    Some college   0.69 0.61-0.77 0.79 0.70-0.88 0.74 0.66-0.83 0.73 0.65-0.82 
    4 years college +   0.40 0.34-0.46 0.48 0.42-0.56 0.44 0.38-0.51 0.52 0.45-0.60 
Race/ethnicity           
   Non-Hispanic white (ref)     1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
   Non-Hispanic black     2.10 1.91-2.30 2.10 1.91-2.31 1.82 1.65-2.01 
   Hispanic     2.08 1.81-2.39 2.16 1.89-2.48 1.97 1.72-2.26 
Smoking behavior           
  Never smoker (ref)       1.00 1.00-1.00 1.00 1.00-1.00 
  Current smoker       0.90 0.80-1.01 1.14 1.00-1.29 
  Former smoker       1.09 1.00-1.18 1.06 0.97-1.15 
Having healthcare (Yes)       3.51 2.75-4.48 3.18 2.49-4.05 
BMI (kg/m2)         1.18 1.16-1.20 
BMI squared         0.99 0.99-0.99 
Survey year           
  1988-1994 (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
  1999-2004 1.31 1.12-1.53 1.39 1.20-1.61 1.34 1.15-1.56 1.28 1.10-1.50 1.10 0.94-1.28 
  2005-2010 1.47 1.26-1.72 1.60 1.38-1.86 1.53 1.31-1.78 1.47 1.26-1.72 1.18 1.01-1.39 
  2011-2016 1.78 1.55-2.05 2.03 1.77-2.33 1.88 1.65-2.16 1.84 1.60-2.12 1.42 1.24-1.64 
ref: Reference group 
NHANES survey design is accounted for. 
Data source: NHANES 1988-1994 and 1999-2016. 
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Table 3-4. Odds Ratios from Multivariate Logistic Regressions for HbA1c ≥ 6.5%. Ages 30-80 (n=42,355).  
 Model 1 Model 2 Model 3 Model 4 Model 5 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Nativity            
US-born (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
Foreign-born 1.36 1.22-1.51 1.15 1.03-1.28 0.79 0.69-0.91 0.83 0.73-0.95 1.05 0.91-1.21 
Age, in years 1.05 1.05-1.05 1.05 1.04-1.05 1.05 1.05-1.05 1.05 1.04-1.05 1.06 1.05-1.06 
Male  1.28 1.18-1.39 1.31 1.21-1.42 1.34 1.23-1.45 1.38 1.27-1.50 1.56 1.43-1.70 
Educational attainment           
    < High school (ref)   1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
    High school graduate   0.67 0.61-0.75 0.77 0.69-0.85 0.74 0.67-0.83 0.73 0.65-0.82 
    Some college   0.67 0.60-0.75 0.78 0.70-0.87 0.74 0.67-0.82 0.72 0.65-0.81 
    4 years college +   0.38 0.33-0.44 0.47 0.42-0.54 0.44 0.38-0.50 0.52 0.45-0.59 
Race/ethnicity           
   Non-Hispanic white (ref)     1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
   Non-Hispanic black     2.31 2.11-2.52 2.32 2.12-2.54 2.01 1.84-2.19 
   Hispanic     2.13 1.86-2.44 2.19 1.92-2.51 1.99 1.73-2.28 
Smoking behavior           
  Never smoker (ref)       1.00 1.00-1.00 1.00 1.00-1.00 
  Current smoker       0.88 0.79-0.99 1.13 1.00-1.27 
  Former smoker       1.10 1.01-1.21 1.08 0.98-1.19 
Having healthcare (Yes)       2.35 1.93-2.87 2.09 1.71-2.54 
BMI (kg/m2)         1.22 1.20-1.24 
BMI squared         0.99 0.99-0.99 
Survey year           
1988-1994 (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
1999-2004 1.17 1.00-1.36 1.24 1.07-1.44 1.19 1.02-1.39 1.15 0.99-1.34 0.95 0.82-1.11 
2005-2010 1.45 1.25-1.69 1.59 1.37-1.85 1.51 1.29-1.76 1.47 1.25-1.71 1.14 0.98-1.32 
2011-2016 1.66 1.44-1.92 1.90 1.64-2.21 1.76 1.52-2.03 1.73 1.49-2.00 1.27 1.10-1.46 
ref: Reference group 
NHANES survey design is accounted for. 
Data source: NHANES 1988-1994 and 1999-2016. 
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 Table 3-5. Odds Ratios from Multivariate Logistic Regressions for Undiagnosed Diabetes. Ages 30-80 (n=5,087). 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Nativity            
US-born (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
Foreign-born 1.40 1.11-1.76 1.46 1.14-1.88 1.48 1.13-1.94 1.44 1.10-1.89 1.53 1.16-2.03 
Age, in years 0.99 0.98-1.00 0.99 0.98-1.00 0.99 0.98-1.00 0.99 0.99-1.00 1.00 0.99-1.01 
Male  1.12 0.91-1.38 1.11 0.90-1.37 1.13 0.91-1.39 1.06 0.85-1.33 1.13 0.90-1.41 
Educational attainment           
    < High school (ref)   1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
    High school graduate   1.16 0.90-1.49 1.17 0.90-1.51 1.18 0.90-1.54 1.18 0.91-1.54 
    Some college   1.13 0.87-1.47 1.15 0.88-1.49 1.21 0.92-1.58 1.21 0.92-1.58 
    4 years college +   1.15 0.86-1.53 1.16 0.86-1.57 1.25 0.92-1.70 1.27 0.94-1.73 
Race/ethnicity           
   Non-Hispanic white (ref)     1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
   Non-Hispanic black     1.17 0.95-1.44 1.18 0.95-1.45 1.18 0.95-1.45 
   Hispanic     1.01 0.78-1.32 0.93 0.72-1.21 0.95 0.74-1.23 
Smoking behavior           
  Never smoker (ref)       1.00 1.00-1.00 1.00 1.00-1.00 
  Current smoker       1.08 0.86-1.36 1.14 0.90-1.44 
  Former smoker       1.09 0.87-1.36 1.07 0.86-1.34 
Having healthcare (Yes)       0.33 0.24-0.46 0.32 0.23-0.44 
BMI (kg/m2)         1.06 1.02-1.11 
BMI squared         0.99 0.99-0.99 
Survey year           
1988-1994 (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
1999-2004 0.54 0.42-0.69 0.53 0.41-0.68 0.53 0.41-0.68 0.56 0.44-0.71 0.53 0.41-0.67 
2005-2010 0.65 0.50-0.85 0.64 0.49-0.83 0.63 0.48-0.83 0.65 0.50-0.86 0.60 0.46-0.78 
2011-2016 0.44 0.34-0.58 0.43 0.33-0.57 0.43 0.33-0.57 0.44 0.33-0.58 0.40 0.30-0.52 
Analytic sample is restricted to those with HbA1c ≥ 6.5%  
ref: Reference group. NHANES survey design is accounted for 
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Table 3-6. The Effect of Duration of Residence on Diabetes Outcomes. Ages 30-80. 
 Self-reported diabetes 
(n=42,355) 
HbA1c ≥ 6.5% 
(n=42,355) 
Undiagnosed diabetesa 
(n=5,087) 
 Model 6 Model 7 Model 6 Model 7 Model 6 Model 7 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Nativity and duration             
US-born (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
Foreign-born             
    < 15  0.59 0.48-0.74 0.78 0.62-0.98 0.68 0.56-0.83 0.96 0.77-1.18 1.82 1.21-2.75 2.01 1.33-3.05 
    15 +  0.88 0.74-1.04 1.03 0.87-1.22 0.89 0.77-1.03 1.08 0.93-1.26 1.33 1.01-1.77 1.40 1.05-1.87 
Model 6 adjusts for age, sex, race/ethnicity, education, smoking behavior, access to healthcare and survey periods. 
Model 7 additionally adjusts for continuous BMI and BMI squared.  
aAnalytic sample was restricted to those with HbA1c ≥ 6.5%.   
aUndiagnosed diabetes is defined as HbA1c ≥ 6.5% without self-reported diabetes. 
ref: Reference group 
NHANES survey design is accounted for. 
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Table 3-7. Sensitivity Analyses. Odds Ratios from Multivariate Logistic Regressions for Different Definitions of Diabetes. Ages 30-80 
(n=25,959). 
 FPG ≥ 126 mg/dL 
 
HbA1c ≥ 6.5% or FPG ≥ 126 mg/dL 
 
HbA1c ≥ 6.5%, FPG ≥ 126 mg/dL or 
Self-reported Diabetes 
 Model 8 Model 9 Model 8 Model 9 Model 8 Model 9 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Nativity              
US-born (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
Foreign-born 0.77 0.65-0.92 0.95 0.79-1.14 0.79 0.67-0.93 0.98 0.82-1.16 0.79 0.67-0.94 0.97 0.82-1.16 
Age, in years 1.05 1.04-1.05 1.06 1.05-1.06 1.05 1.04-1.05 1.06 1.05-1.06 1.05 1.04-1.05 1.06 1.05-1.06 
Male  1.48 1.32-1.66 1.62 1.44-1.83 1.47 1.32-1.65 1.63 1.45-1.84 1.40 1.25-1.55 1.53 1.37-1.71 
Educational attainment             
    < High school (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
    High school graduate 0.82 0.71-0.94 0.82 0.72-0.95 0.82 0.71-0.94 0.83 0.72-0.95 0.83 0.72-0.94 0.83 0.73-0.95 
    Some college 0.74 0.64-0.85 0.74 0.64-0.85 0.73 0.64-0.84 0.73 0.63-0.84 0.75 0.65-0.86 0.75 0.65-0.86 
    4 years college + 0.49 0.41-0.59 0.58 0.48-0.69 0.48 0.40-0.57 0.56 0.47-0.67 0.49 0.41-0.58 0.57 0.48-0.68 
Race/ethnicity             
   Non-Hispanic white (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
   Non-Hispanic black 1.98 1.77-2.23 1.73 1.55-1.94 2.21 1.98-2.46 1.94 1.74-2.16 2.17 1.95-2.42 1.90 1.70-2.12 
   Hispanic 2.07 1.77-2.42 1.90 1.61-2.24 2.09 1.79-2.42 1.91 1.63-2.24 2.14 1.85-2.48 1.97 1.68-2.31 
Smoking behavior             
   Never smoker (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
   Current smoker 0.91 0.78-1.05 1.16 1.00-1.35 0.92 0.80-1.06 1.19 1.03-1.38 0.93 0.81-1.08 1.20 1.03-1.40 
   Former smoker 1.09 0.96-1.24 1.07 0.93-1.22 1.10 0.97-1.25 1.08 0.95-1.24 1.10 0.97-1.24 1.08 0.95-1.22 
Having healthcare (Yes) 1.96 1.59-2.41 1.74 1.41-2.14 1.90 1.52-2.37 1.69 1.36-2.09 1.99 1.62-2.45 1.78 1.45-2.18 
BMI (kg/m2)   1.18 1.16-1.21   1.19 1.16-1.22   1.18 1.16-1.21 
BMI squared   0.99 0.99-0.99   0.99 0.99-0.99   0.99 0.99-0.99 
Survey year             
  1988-1994 (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
  1999-2004 1.32 1.11-1.57 1.14 0.95-1.36 1.18 0.99-1.40 1.01 0.84-1.20 1.13 0.96-1.33 0.96 0.81-1.15 
  2005-2010 1.87 1.59-2.20 1.53 1.31-1.80 1.68 1.44-1.97 1.36 1.18-1.58 1.54 1.33-1.79 1.25 1.08-1.44 
  2011-2016 2.14 1.81-2.53 1.66 1.40-1.96 1.92 1.64-2.26 1.47 1.25-1.73 1.78 1.52-2.07 1.36 1.16-1.59 
All analyses were restricted to those who participated in MEC morning session. NHANES survey design is accounted for. ref: Reference group 
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FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USB: US-born individuals. FB: Foreign-born individuals 
╪: Predicted probability is significantly different from that of U.S.-born individuals at the 0.05 level. 
§: Predicted probability is significantly different from that of foreign-born individuals with < 15 years of duration at the 0.05 level.
╪ ╪ 
╪ § 
Figure 3-1. Predicted Probability of Self-Reported Diabetes, HbA1c ≥ 6.5% and Undiagnosed Diabetes.  
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APPENDIX 
Table A1. The Effect of Self-reported Diagnosed Diabetes and HbA1c on All-cause Mortality. 
 HR 95% CI HR 95% CI 
Diabetes status     
   HbA1c <6.5 % (Ref) 1.00 1.00,1.00 - - 
   HbA1c ≥6.5 % 1.41 1.28,1.55 - - 
   Undiagnosed diabetes (Ref) - - 1.00 1.00,1.00 
   Diagnosed diabetes - - 1.56 1.42,1.72 
Race/ethnicity     
    Non-Hispanic White (Ref) 1.00 1.00,1.00 1.00 1.00,1.00 
    Non-Hispanic Black 1.13 1.02,1.26 1.13 1.02,1.25 
    Hispanic 0.87 0.78,0.98 0.86 0.77,0.96 
    Others 0.69 0.54,0.88 0.69 0.54,0.87 
Male 1.55 1.42,1.69 1.55 1.42,1.69 
Age at baseline  1.07 1.07,1.08 1.07 1.07,1.08 
Educational attainment     
    Less than high school (Ref) 1.00 1.00,1.00 1.00 1.00,1.00 
    High school  0.86 0.78,0.95 0.87 0.79,0.96 
    < 4 years college 0.78 0.70,0.87 0.78 0.70,0.88 
    4 years college + 0.60 0.53,0.69 0.61 0.53,0.70 
Smoking behavior     
    Never (Ref)   1.00 1.00,1.00 1.00 1.00,1.00 
    Current smoker 1.94 1.73,2.17 1.96 1.75,2.19 
    Former 1.26 1.15,1.39 1.26 1.15,1.39 
Drinking status     
    Never (Ref) 1.00 1.00,1.00 1.00 1.00,1.00 
    Former drinker 0.93 0.82,1.04 0.93 0.82,1.05 
    Current drinker 0.82 0.72,0.92 0.82 0.73,0.93 
BMI at baseline 0.97 0.97,0.98 0.97 0.97,0.98 
Not having usual health care  1.03 0.88,1.20 1.00 0.86,1.17 
Complications      
    Hypertension 1.20 1.10,1.30 1.18 1.09,1.29 
    Heart failure  2.18 1.93,2.46 2.12 1.87,2.39 
    Heart attack 1.14 1.01,1.29 1.14 1.01,1.28 
    Stroke 1.50 1.33,1.69 1.47 1.30,1.65 
    Cancer 1.32 1.20,1.45 1.31 1.19,1.44 
Ref: Reference group  
All models adjust for survey period. 
Bold values are significant at the 95% confidence level. 
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Table A2. Effect of Duration of Residence on Diabetes Outcomes.  
 Self-reports diabetes HbA1c ≥ 6.5% Undiagnosed diabetesa 
 Model 4 Model 5 Model 4 Model 5 Model 4 Model 5 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Nativity and duration             
US-born (ref) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00-1.00 
Foreign-born             
    - 5  0.59 0.38-0.92 0.78 0.50-1.21 0.61 0.44-0.86 0.85 0.61-1.18 0.87 0.51-1.48 1.21 0.71-2.03 
    5 – 9 0.59 0.40-0.86 0.79 0.54-1.16 0.64 0.45-0.89 0.92 0.65-1.29 0.95 0.56-1.59 1.36 0.80-2.31 
    10 – 14 0.60 0.43-0.83 0.78 0.56-1.11 0.75 0.56-1.00 1.05 0.77-1.43 1.37 0.90-2.09 1.93 1.27-2.94 
    15 +  0.88 0.74-1.04 1.03 0.88-1.22 0.89 0.77-1.03 1.09 0.94-1.26 1.08 0.86-1.36 1.34 1.06-1.70 
Model 4 adjusts for age- sex- race/ethnicity- education- smoking behavior- access to healthcare and survey periods. 
Model 5 additionally adjusts for BMI and BMI squared.  
aAnalytic sample was restricted to those with HbA1c ≥ 6.5%.   
Undiagnosed diabetes is defined as HbA1c ≥ 6.5% without self-reported diagnosed diabetes.  
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Table A3. Distribution of Age-Standardized Prevalence of Self-reported Diabetes, HbA1c ≥ 6.5%, Undiagnosed Diabetes and BMI 
Classifications by Race/Ethnicity and Nativity.  
 Whites Blacks Hispanics 
 USB FB USB FB USB FB 
N (%)a 19,967(95.5) 948(4.5) 9,203(89.4) 925(10.6) 4,669(35.2) 6,643(64.8) 
Self-reported diabetes 8.6 6.7 15.1 10.9 14.5 11.5 
HbA1c ≥ 6.5% 9.7 7.7 18.1 13.9 16.3 13.9 
Undiagnosed diabetes 25.1 31.2 28.7 29.4 22.7 33.1 
BMI classification       
   Under or normal weight   30.2 34.8 21.5 29.0 18.6 20.9 
   Overweight  35.0 37.7 29.4 41.1 34.3 42.5 
   Obese class Ⅰ 20.4 18.7 23.0 21.0 23.9 24.8 
   Obese class Ⅱ/Ⅲ 14.5 8.7 26.0 8.9 23.2 11.8 
aUnweighted sample size and weighed percentage. 
USB: US-born individuals. FB: Foreign-born individuals
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